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ABSTRACT 
Staphylococcus aureus (S. aureus) infections remain a major challenge for the 
healthcare system, and new treatment options are highly demanded. S. aureus 
is a pathogenic microorganism, responsible for a broad range of clinical 
infections in humans. Septic arthritis, a debilitating joint disease, is mainly due 
to S. aureus. Furthermore, the majority of skin and soft tissue infections are 
also caused by S. aureus. S. aureus expresses multiple bacterial molecules, 
including bacterial lipoproteins (Lpps), which play a role in the disease 
pathogenesis. S. aureus Lpps, the predominant ligands for TLR2, are important 
for bacterial survival due to their role in maintaining the metabolic activity of 
the bacteria. So far, their role in different staphylococcal infections have not 
been fully defined. 
The aim of this thesis was to explore the role of S. aureus Lpp in the mouse 
models for septic arthritis and skin infection. The severity of septic arthritis 
and skin inflammation/infection as well as the molecular and cellular response 
of the host upon S. aureus Lpp exposure was the main focus of the thesis. 
S. aureus Lpp, injected intra-articularly into murine knee joints, induced 
chronic macroscopic arthritis of a destructive character, which was mediated 
by monocytes/macrophages via TLR2. However, co-injection of purified S. 
aureus Lpp with S. aureus into mouse knees resulted in increased bacterial 
elimination. Mice intravenously infected with the S. aureus Lpp-expressing 
Newman parental strain, had increased mortality and weight reduction as well 
as impaired bacterial clearance in kidneys independent of TLR2 compared to 
those mice infected with Lpp-deficient strain. However, Lpp expression had 
no significant impact on the severity of bone destruction. Finally, in a skin 
infection model, expression of Lpp in S. aureus was associated with an 
 enhanced inflammatory response and increased bacterial burden in the local 
infection site. 
In conclusion, S. aureus Lpps play differential roles depending on the route of 
infection. In the case of locally-induced arthritis, S. aureus Lpps play a dual 
role – on the one hand, Lpps contribute to joint inflammation and damage; on 
the other hand, Lpps elicit strong innate immune responses, resulting in 
efficient bacterial elimination. In haematogenous septic arthritis, Lpps have a 
limited impact on arthritis development. Finally, in the skin infection model, 
S. aureus Lpps contribute to local skin inflammation and enhance skin abscess 
formation. 
 
Keywords: Staphylococcus aureus; lipoproteins; TLR2; septic arthritis; skin 
infection; mouse 
  
SAMMANFATTNING PÅ SVENSKA 
Trots stora framsteg inom hälso- och sjukvårdssektorn kvarstår stora utmaningar 
avseende bakterieinfektioner orsakade av gula stafylokocker (Staphylococcus 
aureus) och nya adekvata behandlingsmetoder är således högt efterfrågade. Denna 
bakterietyp förekommer bland omkring hälften av den friska vuxna befolkningen, 
vanligtvis i näsöppningen och som en del av hudfloran. Samtidigt är gula 
stafylokocker kända för att kunna vara aggressiva och är en ledande orsak till 
många kliniska infektioner, såsom led- och hudinfektioner samt livshotande 
blodinfektioner och sepsis. Till sitt förfogande har stafylokocker ett brett register 
av olika molekyler, inklusive lipoproteiner, som den använder till försvar mot vårt 
immunsystem. Bakteriella lipoproteiner uppfyller flera viktiga funktioner hos 
bakterien och är bland annat centrala för bakteriens överlevnad på grund av dess 
roll i att upprätthålla bakteriens metaboliska aktivitet. Lipoproteinernas specifika 
betydelse vid olika stafylokockinfektioner har däremot inte studerats väl. 
I denna avhandling studerade jag lipoproteiners inverkan vid olika 
stafylokockinfektioner i musmodeller, och mer specifikt vid ledsjukdomen septisk 
artrit och vid hudinfektion. Interaktionen mellan stafylokocklipoproteiner och den 
efterföljande immunologiska responsen utforskades främst. 
Sammantaget visar min avhandling att lipoproteiner i stafylokocker orsakar 
bestående och uttalad knäledsinflammation, till följd av ett överaktivt 
immunförsvar som angriper leden. Dessutom ger lipoproteinerna upphov till en 
ökad bakterieeliminering och minskad skada i knäleden i samband med att dessa 
blandas med levande bakterier genom att bidra till ökad aktivering av 
immunsystemet, och resulterar således i två helt olika fenomen. Vidare har jag 
även kunnat påvisa att stafylokocklipoproteiner ger en blodinfektion av svårare 
karaktär och slutligen till att dessa bidrar till framkallandet av hudinfektion med 
ökat inflammatoriskt svar samt hur bakterien tillämpar detta till sin fördel genom 
att skapa ett bättre skydd mot immunförsvaret. 
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1. Introduction 
 
Staphylococcus aureus (S. aureus) is mostly known as being associated with 
dreaded antibiotic-resistant infections, and rightly so, S. aureus plays a much 
broader role in human diseases. On the one hand, S. aureus functions as a 
commensal bacterium, colonizing nearly half of the human population, 
permanently or intermittently (Wertheim et al. 2005). On the other hand, S. 
aureus is a highly pathogenic microorganism with the ability to rapidly utilise 
its pathogenic properties as soon as it evades our body, and it frequently causes 
numerous severe clinical infections in humans, such as osteomyelitis, infective 
endocarditis, infectious arthritis, metastatic abscess formation and device-
related infections (Edwards and Massey 2011; Tong et al. 2015). It is well-
known that S. aureus is a very resourceful and dangerous pathogen in humans 
(Lowy 1998) and the leading cause of bloodstream infections (Edwards and 
Massey 2011). However, the mechanism how S. aureus transitions from 
colonization to infection remains elusive. Thus, gaining a greater 
understanding of its molecular mechanism and host-pathogen interaction is of 
vital importance in order to combat infectious diseases caused by S. aureus. 
Septic arthritis and skin infections, both typically caused by S. aureus, have 
been the focus of this thesis. 
1.1 Septic arthritis 
Septic arthritis, also known as infectious arthritis, remains one of the most 
dangerous and aggressive joint diseases due to its rapidly progressing and 
destructive nature, and is regarded as a potentially life-threatening condition 
(Rutherford et al. 2016). It is most commonly caused by S. aureus (Kaandorp 
et al. 1997), and it accounts for nearly 50% of all of the cases (Goldenberg 
1998), while a variety of other bacterial, viral or fungal infections are also 
known to be implicated (Goldenberg 1998; Tarkowski 2006). Furthermore, S. 
aureus contributes to the most severe cases of infectious arthritis (Colavite and 
Sartori 2014), and is the most predominant cause of bacterial arthritis among 
rheumatoid arthritis and diabetic patients, counting for 80% of all of the cases 
(Goldenberg 1998). The current treatment alternatives are exactly the same as 
those used 30 years ago including antibiotics and drainage of the affected 
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joints. Lack of early or inadequate treatment can be fatal (Mathews et al. 2010). 
Even after initiation of immediate treatment, the joint damage caused by septic 
arthritis is often irreversible (Galloway et al. 2011). As a result of this 
debilitating disease, permanent joint dysfunction occurs in almost 50% of the 
patients (Kaandorp et al. 1995; Goldenberg 1998). Thus, joint replacement 
surgery is often needed. 
Septic arthritis is an infectious disease that leads to an overwhelming 
inflammation in the joints (Colavite and Sartori 2014), and the determination 
of the joint destruction has been extensively studied for the past few decades 
(Mohammad et al. 2016; Mohammad et al. 2019; Mohammad et al. 2020; 
Tarkowski et al. 2001; Fei et al. 2011; Na et al. 2016; Ali, Na, et al. 2015; Ali, 
Welin, et al. 2015; Ali, Zhu, et al. 2015; Fatima et al. 2017; Jarneborn et al. 
2020; Jin et al. 2019). Interplay between the bacterial virulence factors and 
host-immune response is considered to be decisive and of high pathogenic 
importance during the progress of the disease (Colavite and Sartori 2014). The 
disease course is characterized by an exaggerated immune response with rapid 
influx of monocytes and neutrophils, and substantial activation of 
macrophages in the local infection site (Bremell, Abdelnour, and Tarkowski 
1992; Verdrengh et al. 2006), subsequently leading to pannus formation and 
destruction of both cartilage and bone (Colavite and Sartori 2014). 
The incidence of septic arthritis is estimated to be 4-10 cases per 100,000 
individuals in the general population per year (Tarkowski 2006; Mathews et 
al. 2010). Two age groups that are particularly susceptible of acquiring septic 
arthritis are the paediatric population under 15 years of age as well as the 
population over 55 years of age (Nade 2003). However, the frequency of septic 
arthritis in patients with a pre-existing joint disease, such as rheumatoid 
arthritis, or with implants of prosthetic joints, is up to 10 times higher 
compared to the general population (Tarkowski 2006). Thus, the indisputably 
leading risk factors for the onset of septic arthritis are pre-existing joint disease 
as well as orthopaedic joint surgery (Colavite and Sartori 2014; Tarkowski 
2006). Other risk factors that predispose to infectious arthritis include 
increased age, recent surgical intervention of the joint, skin infection, 
immunosuppressive treatment or immunodeficiency, intravenous drug abuse 
and diabetes mellitus (Kaandorp et al. 1995). For example, in rheumatoid 
arthritis, the mortality rate among patients suffering from monoarthritis 
(infection in one single joint) corresponds to 19% (Tarkowski 2006). However, 
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in terms of polyarthritis, a more serious manifestation of septic arthritis and a 
sign of undesirable outcome, the mortality rate amounts to approximately 50% 
(Tarkowski 2006). 
Originating from another infection site such as abscess or pneumonia, bacterial 
dissemination through the bloodstream into the joints is the most common 
route of acquiring septic arthritis (Goldenberg and Reed 1985). S. aureus is 
very prone to escape the immune system and enter the joint cavity. Larger 
peripheral joints are more susceptible to infection (Margaretten et al. 2007), 
with the knee joint accounting for approximately half of the staphylococcal 
septic arthritis cases in humans (Goldenberg 1998). In a mouse model, S. 
aureus is known to induce severe bone erosion within a couple of days after 
infection upon intravenous inoculation (Fatima et al. 2017). However, the 
exact mechanism that haematogenously spreading S. aureus employs to escape 
various immunological checkpoints in the bloodstream before it can cross the 
endothelial barriers along the way, and before it is able to establish new 
infection sites, is still wrapped in mystery (Edwards and Massey 2011). S. 
aureus can also directly enter the joint cavity and induce septic arthritis without 
dissemination through the blood, e.g. due to direct trauma to the joints, during 
intra-articular injections or during prosthetic surgical interventions 
(Goldenberg and Reed 1985), although this is much less common (Shirtliff and 
Mader 2002). 
1.2 S. aureus cutaneous infections 
The human skin, functioning as the largest organ in the body (Grice and Segre 
2011), serves as a critical first line of host defence by which its physical barrier 
efficiently shields against invading pathogens (Kobayashi, Malachowa, and 
DeLeo 2015). The skin along with its underlying soft tissue, which represents 
the majority of the tissue in the body (Dryden 2009), are consistently exposed 
to traumatic wounds or ruptures, which subsequently increases the risk of skin 
and soft tissue infections in humans (Dryden 2009). Skin and soft tissue 
infections belong to a category of infections which are not only ubiquitous, but 
also very common, with most of the population affected at some time point in 
their life span (Dryden 2010). Although S. aureus may reside harmlessly on 
the skin, this microorganism has an immense pathogenic potential and can 
become intensively deleterious under the right circumstances. In fact, S. aureus 
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is well-known to be the most prominent microorganism isolated from skin and 
soft tissue infections (Miller and Cho 2011; McCaig et al. 2006), and 
encompasses a broad spectrum of clinical manifestations, ranging from minor 
and superficial infections to life-threatening conditions (Dryden 2009). 
Classical examples of skin and soft tissue infections are infected ulcers and 
wounds, folliculitis, cellulitis and impetigo (Miller and Cho 2011). More 
severe forms of S. aureus skin infections may transform to bacteraemia, e.g. 
the presence of bacteria in the bloodstream, potentially leading to the infection 
in different organs such as lungs (pneumonia), membranes surrounding the 
brain (meningitis), heart valves (endocarditis) and sepsis (Miller and Cho 
2011; Lowy 1998). S. aureus is notorious for skin abscess formation (Krishna 
and Miller 2012a), and thus to understand the underlying mechanism behind 
this phenomenon has been one of the goals of this thesis. 
1.3 S. aureus and the threat of antibiotic 
resistance 
The fierce combat against S. aureus and its increasing resistance proceeds with 
enhanced global spread and failure of promoting new successful therapeutic 
alternatives remain. This consequently results in severe clinical and economic 
burdens for societies worldwide. As S. aureus possesses an extraordinary 
capability to acquire antibiotic resistance (DeLeo et al. 2010), the spread of S. 
aureus antibiotic-resistant strains and its attributable infections has reached 
epidemic levels worldwide (Chambers and Deleo 2009; Grundmann et al. 
2006). In fact, the emergence of S. aureus resistant strains, including 
methicillin-resistant S. aureus (MRSA), is strongly associated with greater 
incidence and increasingly complicated S. aureus infections of more invasive 
nature, which significantly limits the adequate treatment options (Tong et al. 
2015; DeLeo et al. 2010). In addition, the most severe MRSA infections are no 
longer strictly restricted to hospital intensive care or acute care units, as 
invasive MRSA infections are highly distributed on a considerably broader 
area (Klevens et al. 2007). Furthermore, infections associated to MRSA are 
attributed to both hospital environments as well as to the communities, because 
these can be acquired in both areas – commonly known as healthcare-
associated MRSA and community-associated MRSA, respectively. This 
simply puts not only hospitalised patients at risk but the general and otherwise 
healthy population as well (DeLeo et al. 2010).  
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Of note, S. aureus has been identified as the most prominent cause of infections 
within the health care facilities in the United States, whereby MRSA, in 
particular, accounts for a high proportion of these infections (DeLeo and 
Chambers 2009). Importantly, MRSA is now considered as one of the primary 
causes of increased mortality triggered by a single pathogen (DeLeo and 
Chambers 2009). It is therefore of vital importance to emphasise the magnitude 
of MRSA infections and the consequences they give rise to from a global point 
of view. Hence, better understanding of the underlying mechanisms behind the 
virulent functions of S. aureus infections and its ability to effectively acquire 
resistance may lead to improved and urgently needed therapies. The 
development of effective prophylactic vaccines against S. aureus infections is 
an appealing thought, although no attempts have succeeded so far, most likely 
due to the lack of a clear virulent target in S. aureus (Proctor 2012). 
Immunotherapy has caught the attention of researchers in recent years and is 
indeed an exciting and promising area of research. By harnessing the immune 
system through targeted therapies, an increased host cellular response may 
both promote elimination of invading pathogens as well as pave the way for 
fundamentally novel therapeutic modalities with the goal to overcome the 
immense challenge caused by the rapid emergence of antibiotic-resistant 
bacteria. 
Importantly, sub-inhibitory concentrations of antibiotics promote the release 
of extracellular DNA in S. aureus and the induction of biofilm formation 
(Kaplan et al. 2012). Furthermore, in previous studies, sub-minimal inhibitory 
levels of β-lactam antibiotics have been shown to upregulate expression of 
various S. aureus virulence factors (Dumitrescu et al. 2011; Kernodle et al. 
1995; Stevens et al. 2007; Shang et al. 2019). Overall, it is of outmost 
importance to use the antibiotics accurately during infections – both in terms 
of the selection of the correct drug and adequate/optimal dosage, as well as 
early treatment initiation at the onset of infection. 
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2. S. aureus and its virulence factors 
 
S. aureus is a Gram-positive bacterium that possesses an immense arsenal of 
virulence factors, which enable the bacterium to exercise its perilous potential 
in order to thrive as an opportunist in humans. Some of the virulence factors 
deployed by S. aureus are described below and depicted in Figure 1. 
 
Figure 1. Schematic diagram illustrating the basic structure of 
Staphylococcus aureus and its ability to express various virulence factors.  
TSST-1 = Toxic shock syndrome toxin-1, Clfs = clumping factors, FnBPs = 
fibronectin binding proteins, Cna = Collagen adhesin, Lpp = lipoprotein, 
vWbp = von Willebrand factor-binding protein. 
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2.1 Cell wall components 
The architecture of the cell wall and cell envelope in S. aureus has a complex 
nature. The cell wall comprises a multi-layered structure with peptidoglycan 
(PGN) as the main component (Lowy 1998). PGN is known for its 
characteristically heterogeneous structure and is composed of cross-linked 
polymers arranged with alternating N-acetylglucosamines and N-
acetylmuramic acid sugar residues with β-1,4 linkage formations (Giesbrecht 
et al. 1998; Lowy 1998), corresponding to 20 – 30 nm in thickness (Sharif et 
al. 2009). The cross-linked structure is established through peptide bridges 
consisting of L- and D-amino acids, which form its 3-dimensional structure 
that surrounds the entire bacterium (Lowy 1998). In fact, PGN covers up to 
half of the total weight of the cell wall of S. aureus (Lowy 1998), and serves a 
critical role in upholding the structural integrity of the bacterium as well as 
providing a protective shield against the host (Sorbara and Philpott 2011). 
Through detection by pattern recognition receptors (PRRs), including Toll-like 
receptors (TLRs) and nucleotide-binding oligomerization domain-like 
receptors (NLRs), PGN highly alerts the innate immune system upon exposure, 
as it serves as a microbe‐associated molecular pattern (MAMP) component 
(Sorbara and Philpott 2011). 
S. aureus PGN has previously been shown to induce arthritis in a local mouse 
knee joint model (Liu et al. 2001). However, this is in contrast to our recent 
study where we demonstrated that purified S. aureus PGN only gave rise to 
mild and transient macroscopic arthritis (Paper I) (Mohammad et al. 2019). 
These contradicting findings can be attributed to differences in administered 
doses of PGN or contamination by lipoproteins (Lpps), which is discussed in 
more detail below. 
Besides, secondary modifications of the PGN cell wall are of vital importance 
in order to resist host immune response enforcements (Bera et al. 2005). 
Antibacterial enzymes produced by the host, such as lysozyme, also known as 
muramidase, can cleave PGN in the β-1,4 linkage site localised between the 
sugar residues of N-acetylglucosamine and N-acetylmuramic acid, thereby 
inhibiting bacterial overgrowth (Bera et al. 2005; Keshav et al. 1991). 
However, S. aureus impressively protects itself from ‘cell wall breakdowns’ 
by utilizing O-acetylation modifications mediated by the O-acetyltransferase 
A (OatA) enzyme in the PGN cell wall (Sychantha et al. 2017). We 
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demonstrated that the virulence associated with PGN OatA, in both systemic 
and local S. aureus-induced septic arthritis, showed milder progression of the 
disease in mice infected with a ΔoatA mutant strain (Baranwal et al. 2017), 
indicating the pathogenic importance of the O-acetylation of PGN in 
staphylococcal septic arthritis. 
Among the constituents of the cell wall of S. aureus are the teichoic acids, 
made up of polyribitol- and polyglycerol phosphates as well as sugar-
containing polymers (Reichmann and Grundling 2011; Brown, Santa Maria, 
and Walker 2013). Teichoic acids are not unique to S. aureus but are found in 
various Gram-positive bacteria. They can be categorised into wall teichoic 
acids (WTA) that are covalently attached to the bacterial PGN, and 
lipoteichoic acids (LTA) that are anchored to the lipid membrane through a 
glycolipid (Reichmann and Grundling 2011; Brown, Santa Maria, and Walker 
2013). 
Historically, LTA has been regarded as a potent stimulator of the innate 
immunity upon its recognition by TLR2 among others, leading to the activation 
of the macrophages and the release of pro-inflammatory cytokines (Morath, 
Geyer, and Hartung 2001; Kusunoki et al. 1995; Morath et al. 2002). However, 
recent studies cast a shadow of doubt on these results, pointing a finger to 
contamination by other cell wall components of S. aureus, discussed further 
below. 
WTA has been implicated in the pathogenesis of S. aureus-induced 
endocarditis (Weidenmaier et al. 2005) and endophthalmitis (Suzuki et al. 
2011). LTA, on the other hand, has been shown to damage the skin barrier, 
inducing skin inflammation (Brauweiler, Goleva, and Leung 2019) and 
elevated levels of LTA were recovered in children with infected atopic 
dermatitis lesions (Travers et al. 2010). In addition, LTA is essential in 
shielding the bacteria against antimicrobial peptides (Peschel et al. 1999). 
Capsular polysaccharides (CP) surround the cell wall of S. aureus. So far, 
more than 10 different serotypes of CP have been described, although two 
serotypes, CP5 and CP8 constitute the main serotypes isolated from clinical 
strains (Nanra et al. 2013; Mohamed et al. 2019). One of the functions of the 
CP is to protect the bacteria from the innate immune system by evading 
complement binding and subsequent killing by phagocytes (Guidry et al. 1991; 
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O'Riordan and Lee 2004). In addition, Nilsson et al. showed that the CP5 
serotype is a virulence factor in S. aureus induced septic arthritis and sepsis 
(Nilsson et al. 1997). Furthermore, conjugate vaccine of CP8 but not CP5 
conferred protection against S. aureus induced dermonecrotic skin lesions in 
murine skin infection model (Cheng et al. 2017).  
2.2 Lipoproteins 
Among the wide array of bacterial molecules that S. aureus exhibits are the 
lipoproteins (Lpps), which is the main focus of this thesis.  
The aims of the studies in this thesis were to understand the role of S. aureus 
Lpps in infections, more specifically:  
1. Determine whether S. aureus Lpps are arthritogenic, and if so, to 
elucidate the molecular and cellular mechanism behind it (Paper 
I), 
2. Investigate the importance of S. aureus Lpp and TLR2 in murine 
haematogenous septic arthritis (Paper II), 
3. Study the role of S. aureus Lpp in skin infections (Paper III). 
S. aureus Lpp consists of a lipid-moiety and a protein-moiety. The lipid portion 
is covalently attached to a cysteine residue in the N-terminal region, ultimately 
facilitating its anchoring in the outer leaflet of the bacterial cytoplasmic 
membrane (Nguyen and Gotz 2016). In contrast to S. aureus and other Gram-
positive bacteria, bacterial Lpps are also lipid-anchored in the inner leaflet of 
the outer membrane in Gram-negative bacteria (Braun and Rehn 1969). 
Bacterial Lpps were first discovered a few decades ago in Escherichia coli, 
and named Braun’s lipoprotein after its discoverer, as an S-glyceryl-cysteine 
residue was detected with modifications comprising a trio of fatty acids at its 
N-terminal region (Hantke and Braun 1973). This finding was considered as a 
paradigm and as the starting point for research related to bacterial Lpp. Lpp 
and its functions are discussed in detail below. 
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2.3 Accessory gene regulator (agr) 
The pathogenicity of S. aureus depends on the diversity of virulence factors it 
expresses and secretes such as surface proteins, toxins and enzymes. To 
establish and maintain infections, the bacterium must regulate its virulence 
factors and to deploy the right virulence factors at the right time. For example, 
to establish an infection, the bacterium first needs to adhere to the host’s tissues 
and organs and once it establishes an infection, the next step is invasion and 
further spreading to tissues and organs. 
The majority of virulence factors of S. aureus, of which many are described 
below, are regulated by the agr quorum sensing system (Wang and Muir 2016). 
The agr system is composed of four genes termed agrA – agrD (Vuong et al. 
2000). The agr system functions by sensing the cell density of the bacteria, 
from the exponential- to the stationary growth phase. This is made possible by 
quorum sensing – a cell to cell communication mechanism employed by the 
bacteria – which produces the autoinducer that will guide the bacteria towards 
to a decision when and which virulence genes to upregulate or downregulate 
(Wang and Muir 2016). Therefore, it is of no surprise that agr positive strains 
are pathogenic in different S. aureus infections, such as skin infections 
(Kobayashi et al. 2011; Cheung et al. 2011; Kennedy et al. 2010), septic 
arthritis (Nilsson et al. 1996; Abdelnour et al. 1993), endocarditis (Cheung et 
al. 1994; Powers et al. 2012), and pneumonia (Bubeck Wardenburg, Patel, and 
Schneewind 2007). Furthermore, the disruption of the agr signalling 
ameliorates the spread of S. aureus infections; hence agr has been touted as a 
possible drug target (Otto 2004; Wang and Muir 2016). 
In this thesis, both agr positive (Newman) as well as agr negative (SA113) 
strains (Herbert et al. 2010) have been used. 
2.4 Surface proteins 
Another category of virulence factors possessed by S. aureus is the expression 
of surface proteins (Foster et al. 2014). These bacterial surface proteins, also 
known as cell wall-anchored proteins, are covalently linked to the cell wall 
PGN facilitated by sortase-transpeptidase enzymatic reactions (Foster et al. 
2014; Lacey et al. 2017; Hendrickx et al. 2011). A distinguishing feature 
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among these proteins is a sorting signal domain, featuring a LPXTG motif, 
which enables the enzymatic cleavage to be carried out (Schneewind, Model, 
and Fischetti 1992), ultimately giving rise to a broad range of virulent proteins 
on the surface of the bacterium (Mazmanian et al. 2002; Cheng et al. 2009). So 
far, more than 20 different cell wall-anchored proteins expressed by S. aureus 
have been identified (Foster et al. 2014; Foster 2019), although the number 
varies among different S. aureus strains (Foster et al. 2014; McCarthy and 
Lindsay 2010). These specific proteins play a key role in the survival of the 
bacterium, as they behave in an adhesive, invasive and evasive manner towards 
the host’s tissues and immune response (Foster et al. 2014). The largest class 
of the cell wall-anchored proteins is the microbial surface component 
recognizing adhesive matrix molecules (MSCRAMMs), which facilitate a 
linkage between the microbe and the fibronectin, fibrinogen and collagen of 
the host extracellular matrix, and have a fundamental role in the initial stage in 
the pathogenesis of most S. aureus infections (Patti, Allen, et al. 1994). 
Clumping factors, Staphylococcal Protein A, fibronectin binding proteins, are 
important members of the MSCRAMMs family. 
Clumping factor A (ClfA) is known to favour adhesion to fibrinogen in the 
blood plasma as well as to mediate microbial attachment to indwelling devices. 
This usually promotes biofilm formation, and subsequently enables S. aureus 
to colonize and establish a solid and stable infection evading the immune 
response mounted by the host. Of note, the primary effect of ClfA appears to 
occur at the early stage of infection (Cheng et al. 2009). 
The role of ClfA in various S. aureus infections is significant. In a murine 
septic arthritis model, inoculation with a ClfA mutant S. aureus strain clearly 
reduced the arthritogenicity as well as the mortality rate of mice compared to 
its parental S. aureus Newman strain (Josefsson et al. 2001). Another study 
showed that a deletion mutant of ClfA contributed to less formation of skin 
abscesses in a rabbit model (Malachowa et al. 2016), as well as exhibited 
impaired virulence in mouse skin tissue (Kwiecinski, Jin, and Josefsson 2014). 
Similar to ClfA, ClfB is a fibrinogen binding protein and resembles ClfA with 
regard to its sequence, although ClfB binds to different parts of the fibrinogen 
(Ni Eidhin et al. 1998). Naturally, colonization and subsequent bacterial 
infection of the skin tissue is initiated by adhesion of the bacteria to the 
corneocytes, more specifically the cornified envelope, which surrounds the 
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corneocytes (Fleury et al. 2017). ClfB has been shown to particularly promote 
adhesion of S. aureus in the nares therefore facilitating colonization with 
consequent skin infections (Lacey et al. 2019). Hence, ClfB has been 
implicated in several staphylococcal skin tissue infections (Fleury et al. 2017; 
Lacey et al. 2019). Lacey et al. demonstrated that ClfB could be a vaccine 
target in S. aureus skin and soft tissue infections, inducing both humoral and 
cellular responses (Lacey et al. 2019). ClfB has also been shown to be 
pathogenic in S. aureus experimental endocarditis, albeit to a lesser degree 
than ClfA (Entenza et al. 2000). 
Moreover, we recently assessed whether S. aureus Lpp contributes to enhanced 
ClfA or ClfB levels in comparison to its Lpp deficient strain, but observed that 
Lpp have no impact on the expression levels of these specific virulence factors 
(Paper II) (Mohammad et al. 2020). 
Staphylococcal protein A (SpA), a major S. aureus surface protein, was the 
first to be discovered of the surface proteins (Jensen 1958; Mazmanian, Ton-
That, and Schneewind 2001). Hitherto, all S. aureus clinical isolates contain 
the SpA gene that codes for the protein A (Votintseva et al. 2014). SpA is 
notable for its immune evasion capabilities. It effectively impedes antibody 
recognition by binding to the Fc region of IgG in both humans and mice (Falugi 
et al. 2013). 
Abscess formation is a hallmark of staphylococcal skin infections (Cheng et 
al. 2011; Kobayashi, Malachowa, and DeLeo 2015) and SpA has been found 
to play an important role in skin abscess formation (Cheng et al. 2011). The 
ability to form skin abscess was shown to be diminished in staphylococcal 
mutants lacking SpA compared to their wild-type counterparts (Cheng et al. 
2009; Kwiecinski, Jin, and Josefsson 2014). In patients with atopic dermatitis, 
expression of SpA was more common and was associated with aggravated 
dermatitis lesions (Yao et al. 2010). In murine septic arthritis model, 
administration of bacteria expressing SpA exacerbated not only arthritis but 
also significantly increased the mortality of mice compared to the mutant 
strains lacking the SpA gene (Palmqvist et al. 2002). Interestingly, the level of 
SpA expression was somehow regulated by S. aureus Lpp (Paper II) 
(Mohammad et al. 2020). Total RNA extract from Lpp expressing S. aureus 
strain showed elevated transcriptional levels of SpA compared to the Lpp 
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deficient lgt mutant strain, in early, but not at late hours of bacterial culturing 
(Paper II) (Mohammad et al. 2020). 
Another member of the MSCRAMM family is the collagen adhesion (Cna) 
that binds to collagen, the most abundant protein in the human body and a key 
structure of the connective tissues (Madani, Garakani, and Mofrad 2017). Cna 
facilitates the adhesion of S. aureus to cartilage (Xu et al. 2004), and as a result 
aggravates S. aureus-induced septic arthritis (Xu et al. 2004; Patti, Bremell, et 
al. 1994) and osteomyelitis (Elasri et al. 2002) in murine models. However, 
contradictive findings have been reported regarding the virulence of Cna in 
septic arthritis and osteomyelitis in patients (Thomas et al. 1999; Ryding et al. 
1997; Switalski et al. 1993). 
As mentioned above, Fibronectin binding protein A (FnBPA) and 
Fibronectin binding protein B (FnBPB) are members of the MSCRAMM 
family. Both FnBPA and FnBPB bind to fibrinogen, fibronectin and elastin 
(Pietrocola et al. 2019; Roche et al. 2004; Wann, Gurusiddappa, and Hook 
2000). Similar to several other members of the MSCRAMM family, the FnBPs 
promote adhesion of S. aureus to host cells (Foster et al. 2014). In addition, 
both FnBPs act as invasins, facilitating the internalization of the bacterium into 
epithelial cells (Dziewanowska et al. 1999). 
The FnBPs have been found to promote abscess formation in S. aureus skin 
infections (Kwiecinski, Jin, and Josefsson 2014). Abscess formation was 
diminished in mice inoculated with staphylococcal strains lacking the FnBPs 
compared to mice inoculated with its parental strain (Kwiecinski, Jin, and 
Josefsson 2014). With regard to septic arthritis, FnBPs have been found to be 
of less importance in development of arthritis (Palmqvist et al. 2005). 
However, on the other hand, FnBPs are crucial for inducing systemic 
inflammation leading to significant more weight loss and higher mortality in a 
murine model (Palmqvist et al. 2005). Also, FnBPB expression is more closely 
associated with endocarditis infection than with arthritis or osteomyelitis 
(Tristan et al. 2003). 
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2.5 Secreted molecules 
Most clinical S. aureus isolates secrete coagulase (Coa) and hence expression 
of Coa is used clinically to discriminate S. aureus from other staphylococcal 
species (McAdow, Missiakas, and Schneewind 2012; Lowy 1998). Coa 
promotes clotting of blood by binding to and activating prothrombin which 
will convert fibrinogen to fibrin (Cheng et al. 2010; Lowy 1998), an evasion 
mechanism by S. aureus to shield itself from phagocytosis. In S. aureus 
induced osteomyelitis, Coa aggravates bone loss as well as bone destruction 
by inhibiting the proliferation of osteoblasts (Jin et al. 2013). 
Von Willebrand factor-binding protein (vWbp) is a bacterial enzyme 
secreted by S. aureus and similar to Coa, is involved in host’s clot formation 
by activating prothrombin that in turn cleaves fibrinogen to fibrin (Cheng et al. 
2010; McAdow, Missiakas, and Schneewind 2012). Additionally, as its name 
suggests, vWbp acts as a bridge between the bacterial cell wall and von 
Willebrand factor (vWf) therefore enabling adhesion of S. aureus to vascular 
tissues (Claes et al. 2014; Cheng et al. 2011; Claes et al. 2017).  
In contrast to Coa and vWbp that promote formation of fibrin clots, the 
staphylokinase (Sak) protein produced by S. aureus has the opposite role, 
namely, activating plasminogen to form plasmin that leads to the digestion of 
fibrin clots. Thus, S. aureus directly influences the host fibrinolytic system 
using it to its advantage to spread to new tissues (Molkanen et al. 2002). In S. 
aureus skin infections, dual roles of Sak were described. On the one hand, Sak 
facilitated establishment of infection, while on the other hand, it attenuated 
disease severity by promoting drainage of the formed abscesses (Kwiecinski 
et al. 2013). Furthermore, activation of the host’s plasminogen by Sak 
attenuated S. aureus systemic infection in mice (Kwiecinski et al. 2010). 
2.6 Toxins 
One of the properties that make S. aureus such a formidable threat is the vast 
amount of toxins it secretes. Toxins produced by S. aureus are usually 
categorised into three different groups depending on their functions; 
superantigens, cytotoxins and exfoliative toxins (Oliveira, Borges, and Simoes 
2018).  S. aureus produces quite many superantigens that fall into three 
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categories,  staphylococcal enterotoxins (SEs), staphylococcal enterotoxin-
like toxins (SEls) and toxic shock syndrome toxin-1 (TSST-1) (Xu and 
McCormick 2012). 
The SEs, in turn consist of SEs A, B, C, D, E, G, H, I, R and T whereas the 
SEIs consist of J, K, L, M, N O, P, Q, S, U, V, and X (Xu and McCormick 
2012; Argudin, Mendoza, and Rodicio 2010). Both, the SEs and SEIs, have 
quite similar structures. The main difference is that the SEs are able to induce 
emesis that leads to diarrhoea and vomiting associated with food poisoning 
(Xu and McCormick 2012), whereas SEIs generally do not (Xu and 
McCormick 2012; Argudin, Mendoza, and Rodicio 2010). 
TSST-1 released by S. aureus can cause the potentially fatal toxic shock 
syndrome (TSS) that is characterized by fever, rash and low blood pressure 
rapidly progressing to shock with multiple organ failure (Lappin and Ferguson 
2009). TSST-1 prompts the major histocompatibility complex (MHC)-II on 
antigen-presenting cells to bind non-specifically to receptors of the T-cells, 
circumventing the normal antigen-presenting phase and leading to massive 
activation of T-cells (Fraser 2011). In fact, certain studies have shown that up 
to one fifth of all the T-cells can be activated in patients with TSS (Rodstrom, 
Elbing, and Lindkvist-Petersson 2014). This is followed by a cytokine storm 
with enormous release of various cytokines and chemokines (Low 2013; Kong, 
Neoh, and Nathan 2016). The majority of non-menstrual TSS cases as well as 
all menstruation-associated TSS are caused by TSST-1 (McCormick et al. 
2003). 
In haematogenous S. aureus septic arthritis model, TSST-1 was shown to 
aggravate the disease severity (Abdelnour, Bremell, and Tarkowski 1994). 
Mice intravenously injected with TSST-1 secreting S. aureus developed more 
frequent and severe arthritis compared to mice inoculated with TSST-1 
deficient S. aureus (Abdelnour, Bremell, and Tarkowski 1994). However, 
direct injection of purified TSST-1 into mouse knee joint failed to induce joint 
inflammation (Paper I) (Mohammad et al. 2019). 
Thus far, four different exfoliative toxins (ETs) released by S. aureus have 
been identified, named ETA – ETD (Oliveira, Borges, and Simoes 2018). The 
exfoliative toxins, especially A and B released by S. aureus, are responsible 
for causing staphylococcal scalded skin syndrome (Leung, Barankin, and 
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Leong 2018; Handler and Schwartz 2014). The syndrome, occurring mostly in 
children, is associated with blistering of the skin and is considered a paediatric 
emergency. It can be fatal, especially in adults (Leung, Barankin, and Leong 
2018; Handler and Schwartz 2014). 
Among the arsenal of toxins secreted by S. aureus are the pore forming, cell-
membrane damaging cytotoxins including the haemolysins, bi-component 
leucocidins and the phenol-soluble modulins. 
The haemolysins, made up of α, β, and γ haemolysins, are pore-forming toxins 
that cause lysis of the red blood cells. Of these, the α-haemolysin, even referred 
to as the α-toxin, is the most studied and has been shown to cause lysis of 
several type of mammalian cells, not only the red blood cells (Bhakdi and 
Tranum-Jensen 1991). The α-haemolysin has been implicated in the 
pathogenesis of several S. aureus caused diseases including  septic arthritis 
(Nilsson et al. 1999), skin diseases (Walev et al. 1993; Hong et al. 2014), 
pneumonia (Kebaier et al. 2012), and sepsis (Cremieux et al. 2014). 
The bi-component leucocidins target the leukocytes, especially the 
phagocytes, thus preventing the elimination of S. aureus by the host’s immune 
cells (Spaan, van Strijp, and Torres 2017; Alonzo et al. 2012). Chief among 
them is the Panton-Valentine Leucocidin, even known as the LukSF-PV, 
which is overrepresented in S. aureus isolates that cause necrotic skin lesions 
(Adler et al. 2006). 
The phenol-soluble modulins (PSMs) consist of small peptides and similar to 
the haemolysins and leucocidins have pore-forming properties. The PSMs can 
target several cell types such as erythrocytes and leukocytes and have been 
shown to induce inflammation (Cheung et al. 2014). Members of this family 
include the PSM-mec, PSMα 1-4, PSMβ 1-2 as well as PSMγ (Cheung et al. 
2014; Qin et al. 2016).  Apart from the role in biofilm structuring and dispersal 
(Periasamy et al. 2012; Cheung et al. 2014; Peschel and Otto 2013), PSMs 
facilitate invasion and killing of osteoblasts thereby aggravating S. aureus-
induced osteomyelitis (Rasigade et al. 2013). 
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3. The immune response in infections 
caused by S. aureus  
 
S. aureus, through its vast virulence factors, seeks multiple ways to colonize 
and establish infections in humans. However, upon intrusion, this pathogenic 
bacterium highly alerts the host's immune system. Consequently, a battle 
between the host and the pathogen starts. Some of the complications and 
immune responses that arises upon the host-pathogen interactions during septic 
arthritis and skin infection are briefly discussed in this chapter. 
3.1 Innate immunity 
The host's innate immune system immediately executes a series of protective 
measures against intruding pathogens, such as S. aureus, and this serves as the 
first line of defence (Akira, Uematsu, and Takeuchi 2006). This action is 
initially implemented through recognition via PRRs that distinctively sense 
pathogenic components and promptly trigger the activation of innate immune 
cells (Akira, Uematsu, and Takeuchi 2006). Among these immune cells are the 
phagocytes. 
3.1.1 Neutrophils and macrophages 
The most abundant type of the leukocytes are the polymorphonuclear 
neutrophils, making up to 50-70% of the white blood cells in humans (Mestas 
and Hughes 2004). Neutrophils are a subset of granulocytes and an 
indispensable part of the innate immunity. Neutrophils are under normal 
conditions confined in the bloodstream and can be quickly recruited to tissues 
and organs upon S. aureus infection through chemotaxis. They play a critical 
role in eliminating the bacteria (Kolaczkowska and Kubes 2013). PRRs resided 
on the surface of the neutrophils facilitate the detection of S. aureus and 
subsequently opsonisation and phagocytosis (van Kessel, Bestebroer, and van 
Strijp 2014). Phagocytosis of the bacteria is followed by the release of reactive 
oxygen species and antimicrobial peptides by the neutrophils that result in 
degradation and ultimately elimination of the pathogen (Guerra et al. 2017). 
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Macrophages are, unlike the neutrophils, mononuclear and account for less 
than 10% of the leukocytes. The precursors to macrophages are the monocytes 
that circulate in the blood and which upon activation can differentiate to 
macrophages. The macrophages are the main source of numerous important 
cytokines and chemokines that play an important part of the immune response. 
Depending on their point of entry to the body, pathogens would first encounter 
tissue resident macrophages that are usually confined to specific organs such 
as Kupffer cells in the liver, osteoclasts in the bones or alveolar macrophages 
in the lungs (Kierdorf et al. 2015). 
As expected, macrophages were shown to be essential in bacterial elimination, 
thus ridding the body of the invading pathogen (Verdrengh et al. 2006). 
However, it has also been demonstrated that macrophages aggravate the 
arthritis severity in a murine model of live S. aureus-induced septic arthritis 
(Verdrengh et al. 2006), potentially due to enhanced secretion of the pro-
inflammatory cytokine, TNFα (Hultgren et al. 1998). In the case of arthritis 
induced by antibiotic-killed S. aureus, a close crosstalk between macrophages 
and neutrophils is necessary for induction of joint inflammation (Ali, Zhu, et 
al. 2015). 
We recently demonstrated that purified S. aureus Lpp rapidly initiates the 
recruitment of monocytes/macrophages and neutrophils upon local knee 
injection (Paper I) (Mohammad et al. 2019). A similar outcome with influx of 
inflammatory cells was also observed in the skin model (Paper III). Yet, 
leukocyte depletion was shown to diminish the Lpp-induced effect (Paper III). 
In the model of local knee arthritis induced by purified S. aureus Lpp, depletion 
of monocytes/macrophages resulted in diminished bone destruction, whereas 
neutrophil depletion played a minor role (Paper I) (Mohammad et al. 2019). 
This demonstrates that monocytes/macrophages are the key cell types in the 
development of local knee arthritis induced by purified Lpl1. Importantly, 
when purified Lpl1 and live S. aureus were co-injected into murine knee joints, 
bacterial eradication occurred. This was mediated through 
monocytes/macrophages and mainly neutrophils, since depletions of these 
phagocytes resulted in aggravated disease severity and increased bacterial 
burden in local knee joints (Paper I) (Mohammad et al. 2019). Although S. 
aureus Lpps are known as potent stimulators of nitric oxide synthase and 
mediate nitric oxide production in mouse macrophages (Kim et al. 2015), our 
data showed that anti-nitric oxide synthase treatment had no impact on the 
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bacterial clearance in knee joints (Paper I) (Mohammad et al. 2019). In the 
haematogenous S. aureus-induced septic arthritis model, neutrophils are 
known to mediate critical protection as neutrophil-depleted mice exhibited 
more severe disease (Verdrengh and Tarkowski 1997). In addition, in the S. 
aureus skin infection model, Mölne et al. demonstrated that neutrophil 
depletion worsens the disease severity with increased bacterial burden in the 
skin tissue of mice (Molne, Verdrengh, and Tarkowski 2000). These results 
indicate that neutrophils play a critical protective role in both local as well as 
systemic arthritis and S. aureus skin infections (Mohammad et al. 2019; 
Molne, Verdrengh, and Tarkowski 2000; Verdrengh and Tarkowski 1997), 
while monocytes/macrophages play a detrimental role (Mohammad et al. 
2019; Verdrengh et al. 2006). 
3.2 Adaptive immunity 
3.2.1 T- and B-cells 
T-cells and B-cells constitute the major cell types involved in adaptive 
immunity. T-cells originate from the bone marrow, and migrate to the thymus 
where they mature and differentiate into several different subtypes among 
which CD8+, CD4+ and regulatory- T-cells are the most important ones. CD8+ 
cells, even referred to as cytotoxic T-cells are known for killing tumour cells 
as well as virus infected cells (Pennock et al. 2013; Rosendahl Huber et al. 
2014). CD4+ T-cells, even known as T-helper cells, do not have killing 
capacity on their own but rather coordinate with and help other immune cells 
in eliminating the invading pathogen. CD4+ T-cells are in turn divided into 
several subtypes, such as Th1, Th2 and Th17 T-cells (Pennock et al. 2013; Zhu, 
Yamane, and Paul 2010). Regulatory T cells have the ability to supress 
immune responses of other cell types and have an important role in the 
maintenance of self-tolerance. 
Recently, in a murine model, it was shown that CTLA4-Ig, a fusion protein 
that inhibits the second co-stimulatory signal required for activation of T-cells, 
significantly aggravated S. aureus-induced septic arthritis (Ali, Welin, et al. 
2015). However, in another murine S. aureus-induced septic arthritis study, it 
was demonstrated that CD4+ T-cells aggravate disease severity since CD4+ T-
cell depletion resulted in attenuated arthritis (Abdelnour et al. 1994). On the 
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other hand, mice in CD8+ T-cell depletion group exhibited similar outcomes 
as a control group, and CD8+ T-cells were thus shown to play a minor role in 
murine S. aureus-induced septic arthritis (Abdelnour et al. 1994). 
In S. aureus Lpp-induced synovitis, our results revealed that T-cells play a 
minor role in the disease severity upon intra-articular injection of Lpl1 in the 
local murine knee model, as CD4+ and CD8+ T-cell depletion as well as 
CTLA4-Ig treatment gave rise to similar outcomes in the treated groups as in 
the control group (Paper I) (Mohammad et al. 2019). This suggests that T-
cells in general were of minor importance in S. aureus Lpp-induced arthritis 
(Mohammad et al. 2019). 
In S. aureus-induced skin infection model, a recent study showed that purified 
Lpp caused skin inflammation, accompanied with interferon γ producing T cell 
accumulation (Saito and Quadery 2018). CD4+ T-cells have been suggested to 
offer protection against secondary S. aureus skin and soft tissue infections 
(Montgomery et al. 2014). 
B-cells constitute the other major arm of adaptive immunity. B-cells are known 
for secreting antibodies and thus play a key role in conferring humoral 
immunity. B-cells develop in the bone marrow and later migrate to the spleen 
for further maturation (Loder et al. 1999). In S. aureus-induced septic arthritis, 
B-cells play minor role compared to the other cell types, as mice deficient in 
B-cells displayed similar outcomes as their wild-type controls (Gjertsson et al. 
2000). In the case of Lpp-induced joint inflammation, intra-articular injection 
of S. aureus Lpp did not trigger the influx of either B- or T-cells (Paper I) 
(Mohammad et al. 2019). In S. aureus skin infection, B-cells are known to 
produce antibodies that are directed against S. aureus virulence factors, and 
thus mediate important immune responses against the pathogen (Krishna and 
Miller 2012b). 
3.3 Toll like receptors 
Among the PRRs of the innate immune system are the TLR family, which 
plays a critical role in S. aureus recognition (Askarian et al. 2018). All TLRs 
possess a cytoplasmic Toll/interleukin–1 receptor (TIR) domain that enables 
initiation of intracellularly mediated signalling pathways (Takeda and Akira 
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2004). Several members of the TLRs contribute to the detection of conserved 
S. aureus molecules (Askarian et al. 2018), while TLR4 is a key PRR that 
detects lipopolysaccharide  in Gram-negative bacteria (Takeuchi et al. 1999). 
TLR2 serves as a critical receptor for Lpp and also recognises synthetic 
lipopeptides (Aliprantis et al. 1999). It has been demonstrated that S. aureus 
Lpps, in fact, are considered as the most potent components in activating TLR2 
(Hashimoto, Tawaratsumida, Kariya, Aoyama, et al. 2006; Hashimoto, 
Tawaratsumida, Kariya, Kiyohara, et al. 2006). TLR2 and its interaction with 
S. aureus Lpps are discussed in more detail below. 
3.4 Chemokines and cytokines 
Chemokines and cytokines play an essential role in cellular cross-talk during 
infectious and inflammatory conditions. Once secreted from the immune cells, 
they help to promote the recruitment and direct the activity of other immune 
cells in order to fight the infection/inflammation. While these molecules are a 
vital part of all inflammatory processes, pro-inflammatory cytokines can, when 
secreted in excessive levels, participate in aggravation of inflammatory and 
autoimmune diseases, such as rheumatoid arthritis (Feldmann, Brennan, and 
Maini 1996). Among the neutrophil chemoattractant chemokines are 
keratinocyte chemoattractant (KC) and macrophage inflammatory protein-2 
(MIP-2) that originate from monocytes and macrophages (De Filippo et al. 
2008). These are considered as the main recruiters of neutrophils and serve as 
ligands for the CXCR2 receptor (De Filippo et al. 2008; Lee et al. 1995). 
Furthermore, monocyte chemoattractant protein 1 (MCP-1) is a critical 
recruiter of monocytes/macrophages, while TNFα, IL-1, and IL-6, among 
others, are important pro-inflammatory cytokines that are involved in the 
upregulation of local and systemic inflammatory response.  
The role and involvement of these chemokines and cytokines in murine S. 
aureus-induced infectious arthritis and skin infection are described briefly 
here. 
IL-1 has been shown to be involved in the pathogenesis of septic arthritis (Ali, 
Na, et al. 2015; Hultgren, Svensson, and Tarkowski 2002). We recently 
showed that mice treated with IL-1 receptor antagonist (IL-1Ra), and infected 
with S. aureus had increased mortality and exhibited clinically and 
histologically more severe and frequent septic arthritis (Ali, Na, et al. 2015). 
We therefore assessed IL-1 importance in Lpl1-induced synovitis by treating 
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mice with IL-1Ra. Our results demonstrated that IL-1 did not play a major role 
in the induction of synovitis in this specific arthritis model (Paper I) 
(Mohammad et al. 2019). 
The importance of TNF has also been studied in the context of staphylococcal 
infections. TNF has been shown to promote enhanced arthritis frequency in the 
haematogenous infection model while using a double deficient mouse strain, 
lacking TNF and lymphotoxin-alpha (Hultgren et al. 1998). Furthermore, Fei 
et al. previously demonstrated that anti-TNF therapy in combination with 
antibiotics led to favourable outcomes in murine septic arthritis (Fei et al. 
2011). Intriguingly, anti-TNF treatment alleviated arthritis induced by 
antibiotic-killed S. aureus in local murine knee joints (Ali, Zhu, et al. 2015), 
further demonstrating a potent role of TNF in septic arthritis. Thus, we 
explored whether TNF inhibition had any beneficial effects in the Lpl1-
induced synovitis by treating the mice with anti-TNF treatment (etanercept). 
TNF was indeed partially involved in modulating the arthritogenic effects in 
local S. aureus Lpl1-induced knee arthritis (Paper I) (Mohammad et al. 2019). 
Furthermore, inhibition of TNF was shown to reduce the skin lesions in mouse 
model of S. aureus skin infection (Na et al. 2017). 
Decreased arthritis severity is closely associated with lower levels of IL-6 in 
local joints, suggesting that IL-6 is an important cytokine for maintenance of 
septic arthritis (Paper I) (Mohammad et al. 2019). We also demonstrated that 
S. aureus Lpps trigger the quick release of KC and MIP-2 in local tissues 
including knees and skin with enhanced influx of phagocytes, consequent 
inflammation and tissue damages (Paper I and III) (Mohammad et al. 2019). 
3.5 Formation of S. aureus skin abscess and 
interplay with immune cells 
Skin abscess lesions, not unique to S. aureus infections, are characterized as 
an infectious cavity filled with pus or translucent fluid within or below the skin 
surface, which may induce fluctuant swelling (Dryden 2009). Although most 
of the skin abscess lumps are self-limited and harmless, more serious cases are 
associated with a poorer outcome since S. aureus can disseminate within the 
blood and establish mature infections in virtually any of our internal organ 
systems (Kobayashi, Malachowa, and DeLeo 2015). Defects in the skin 
barrier, due to breaches or abrasions in the skin tissue, enable S. aureus to 
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penetrate into the damaged site and enter the underlying tissue. Once the 
bacterium has penetrated through the skin, resident immune cells, such as 
Langerhans cells and macrophages detect the pathogen and generate a rapid 
host inflammatory response at the local infection site (Miller and Cho 2011; 
Krishna and Miller 2012a). An interplay between the host immune system and 
the bacteria takes immediately place, and secretion of chemokines and 
cytokines is induced, which triggers the recruitment of phagocytes, specifically 
neutrophils (Miller and Cho 2011). As a result of the host's immune response, 
an abscess forms around the bacteria, known as a fibrous capsule, in order to 
try to eliminate as well as to limit the spread of S. aureus (Miller and Cho 
2011). At the same time, S. aureus also possesses the ability to aide fibrin clots 
by using its component, Coa, as underscored earlier. The process of S. aureus 
skin abscess formation and the cutaneous immune response is depicted in 
Figure 2. 
 
Figure 2. Illustration of Staphylococcus aureus skin abscess formation and 
cutaneous immune response.  
Defects in the skin barrier enable S. aureus to enter the hosts´ underlying 
tissue. The invading pathogen interacts with resident immune cells which 
triggers the release of chemokines and pro-inflammatory cytokines followed 
by recruitment of neutrophils and abscess formation. 
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4. Bacterial lipoproteins 
4.1 Biosynthetic pathway of lipoproteins 
As an important part of the bacterial cell envelope homeostasis, lipidation of 
proteins naturally occurs as a posttranslational molecule reformation process, 
which ultimately forms mature Lpp in both Gram-positive and Gram-negative 
bacteria (Buddelmeijer 2015). Prior to Lpp maturation, precursor Lpp 
containing signal peptide with characteristic ‘lipobox’ undergoes a series of 
events in order to become lipidated. Initially, the precursor Lpps are 
transported into the cytoplasmic membrane through the general secretory (Sec) 
pathway, or in some cases via the twin arginine translocation (Tat) machinery, 
depending on the conformation of the protein (Hutchings et al. 2009). Pre-Lpp 
functions as precursor of Lpp and comprises an average of 16-27 amino acid 
long signal peptide sequence, resided at the N-terminal region, which is 
recognised by these protein-transporting machineries (Schmaler et al. 2010; 
Hayashi and Wu 1990). Importantly, this signal peptide also contains a specific 
motif at its C-terminal region, commonly known as the lipobox (Kovacs-
Simon, Titball, and Michell 2011). The lipobox, characterized by a three-
amino-acid sequence that is conserved and located in front of the indispensable 
cysteine residue (Nguyen and Gotz 2016), has an essential role in both guiding 
these proteins to the biosynthetic Lpp modification manufacturing site as well 
as in processing them into mature forms (Hutchings et al. 2009). Lpp 
modifications occur within the cytoplasmic membrane of the bacteria and are 
catalysed by three enzymes: 1) pre-Lpp diacylglyceryl transferase (lgt); 2) pro-
Lpp signal peptidase (lsp); and 3) apo-Lpp N-acyltransferase (lnt) (Nakayama, 
Kurokawa, and Lee 2012; Sankaran and Wu 1994).  
The first enzyme, lgt enables the transfer of a diacylglyceryl group from a 
phospholipid onto the thiol group located at the cysteine residue at the 
conserved lipobox motif (Schmaler et al. 2010; Nguyen and Gotz 2016; 
Tokunaga, Tokunaga, and Wu 1982; Sankaran and Wu 1994). Modification of 
the thiol group consequently allows membrane attachment and converts the 
pre-Lpp into a pro-Lpp (Kovacs-Simon, Titball, and Michell 2011). Followed 
by this lipidation, the pro-Lpp becomes recognizable by lsp, which 
subsequently cleaves the signal peptide at the N-terminal region (Hussain, 
Ichihara, and Mizushima 1982). This generates a newly formed amino-
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terminal group at the cysteine residue that comprises a S-diacyl-glyceryl-
cysteine residue and gives rise to the apo-Lpp, also known as the diacylated 
Lpp, which serves as a mature form of Lpp (Nakayama, Kurokawa, and Lee 
2012). Finally, the lnt enzyme, which catalyses the third reaction, facilitates 
the transfer of another fatty acid derived from another phospholipid to the 
cysteine residue ultimately forming a triacylated Lpp structure (Nakayama, 
Kurokawa, and Lee 2012; Sankaran, Gupta, and Wu 1995). In contrast to the 
diacylated Lpp, the triacylated Lpp comprises an N-acyl-S-diacylated cysteine 
residue (Kurokawa, Ryu, et al. 2012). This biosynthetic pathway was initially 
described in Gram-negative Escherichia coli (Tokunaga, Tokunaga, and Wu 
1982), and serves as the canonical biosynthetic pathway in Lpp (Nakayama, 
Kurokawa, and Lee 2012). Lnt is a necessity in most Gram-negative bacteria 
as the addition of the third fatty acid enables the Lpp to either maintain in the 
inner membrane or to release them to the outer membrane via a transporting 
pathway known as the localization of Lpp (Lol) system (Fukuda et al. 2002). 
However, the presence of the lnt homologues had so far only been 
demonstrated in certain Gram-positive bacteria with high-guanine-cytosine 
(GC) content, including mycobacteria (Tschumi et al. 2009; Brulle et al. 2010), 
streptomyces (Widdick et al. 2011), and Corynebacterium (Mohiman et al. 
2012), while the typical Escherichia coli lnt homolog had still not been 
detected in low-GC content Gram-positive Firmicutes (Nakayama, Kurokawa, 
and Lee 2012). Therefore, it was supposed that S. aureus Lpps express a 
diacylated structure (Stoll et al. 2005). However, with the development of GC-
MS technology, it has been shown that Lpp from Gram-positive bacteria may 
have different lipid structures (Kurokawa, Kim, et al. 2012), for example S. 
aureus containing tri-acylated Lpp. It indicates that the involvement of an 
unidentified lnt homolog does in fact exist in some low-GC content Gram-
positive bacteria, such as S. aureus  (Kurokawa et al. 2009; Asanuma et al. 
2011; Navarre, Daefler, and Schneewind 1996; Shahmirzadi, Nguyen, and 
Gotz 2016; Stoll et al. 2005) and Bacillus subtilis (Hayashi et al. 1985). 
Intriguingly, it was later revealed that S. aureus, in fact, does possess a 
triacylated lipid-moiety (Kurokawa et al. 2009). However, the lack of lnt 
homolog still raised the enigmatic question of how S. aureus is capable of 
forming triacylated mature forms of Lpp. Evidence points toward that S. 
aureus bears another type of acyltransferase, and this enzyme serves as a 
prerequisite in ultimately yielding the triacylated lipid-moiety structure of the 
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Lpp (Kurokawa et al. 2009). Furthermore, Asanuma et al. provided structural 
evidence of N-acylation of the lipid-moiety through α‐aminoacylation at the 
lipidated cysteine residue in S. aureus, which enabled the addition of a third 
and last fatty acid that ultimately gave rise to the triacylated S. aureus Lpp 
structure (Asanuma et al. 2011). In addition, triacyl-Lpp structures were 
detected in several S. aureus strains as well as in S. epidermidis (Asanuma et 
al. 2011). However, certain factors, such as bacterial growth phase and acidic 
pH, have been shown to alter the conversion from di- to triacyl-Lpp in S. 
aureus (Kurokawa, Kim, et al. 2012). Prior to this study, it was widely believed 
that in each bacterium, bacterial Lpps were consistent in forming one lipidated 
structure exclusively, independently of the influence of the environmental 
conditions (Nakayama, Kurokawa, and Lee 2012). As a result of the important 
finding demonstrated by Kurakowa et al. (Kurokawa, Kim, et al. 2012), the 
concept that each bacterium is biosynthetically processed in an unperturbed 
manner ultimately leading to either a diacylated or triacylated Lpp, has thus 
changed. Potential reasons for these structural Lpp alterations in S. aureus 
might be due to a possible down-regulation of the specific enzyme that 
facilitates the addition of a third fatty acid with regard to its activity or 
specificity during specific environmental conditions that consequently may 
inhibit its catalysing functions. 
Previous study identified a conserved Lpp structure containing an N-acyl-S-
monoacyl-glyceryl-cysteine, termed the lyso form, which exists in several low-
GC Gram-positive bacteria, including Bacillus cereus, Enterococcus faecalis, 
Streptococcus sanguinis, and Lactobacillus bulgaricus (Kurokawa, Ryu, et al. 
2012). The mechanism behind the lyso structure formation was unknown until 
recently as Armbruster et al. successfully identified the gene product that 
facilitates this particular reaction, commonly known as the Lpp intramolecular 
transferase (lit) enzyme, which distinctly differs from the canonical lnt enzyme 
that plays an essential role in forming the triacylated Lpp structure in Gram-
negative bacteria (Armbruster and Meredith 2017). The authors propose that 
the lit enzyme permits the transfer of a fatty acid to the lipidated cysteine by 
utilizing an internal transferring mechanism that reallocates one of the fatty 
acids from the diacylglycerol moiety to the α-amino group in low-GC Gram-
positive bacteria, including Enterococcus faecalis and Bacillus cereus 
(Armbruster and Meredith 2017). In fact, it was very recently reported that the 
lit enzyme facilitated this intramolecular transfer process through involvement 
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of acyl chain migration (Armbruster, Komazin, and Meredith 2020). 
Furthermore, in Listeria monocytogenes, it was recently demonstrated that the 
lit ortholog, lit2, has a copper-induced expression effect, which consequently 
transforms the lipid-moiety structure as it shifts from being diacylated to form 
a lyso Lpp structure (Armbruster, Komazin, and Meredith 2019). 
Importantly, in a very recent study, it was revealed that a two-component 
system, denoted the Lpp N-acylation transferase system (lns), was responsible 
for the N-acylated triacyl-Lpp form in S. aureus (Gardiner et al. 2020), which 
distinguishably differs from the lnt enzyme that is implemented in Gram-
negative bacteria (Gupta and Wu 1991; Robichon, Vidal-Ingigliardi, and 
Pugsley 2005; Wiktor et al. 2017). The two genes, lnsA and lnsB, were found 
to be exclusively presented in staphylococcal species that are currently known 
to possess a triacylated Lpp lipid-moiety and did not exhibit any similarities 
with neither the lnt nor the lit bacterial Lpp N-acylating enzymes (Gardiner et 
al. 2020). The pivotal role of lnsAB in yielding the triacylated Lpp structure in 
S. aureus was further strengthened by the fact that a disruption of this two-
gene system reverted the S. aureus triacylated Lpp into diacylated Lpp 
(Gardiner et al. 2020). This important finding regarding S. aureus Lpp 
conversion might actually explain how S. aureus is able to form di- or triacyl-
Lpp structures depending on the environmental factors as Kurokawa and 
colleagues reported earlier (Kurokawa, Kim, et al. 2012), and also suggest that 
lnsA and/or lnsB are sensitive to such environmental parameters. Gardiner et 
al. further showed that while integrating lnsA and lnsB into the genome of 
Listeria monocytogenes, the Lpp structure changes from initially being 
diacylated to becoming triacylated (Gardiner et al. 2020). The interesting 
finding of this new staphylococcal Lpp tailored machinery will most likely 
initiate more studies in the near future that hopefully will provide a more 
detailed insight of their functions. The biosynthetic pathway of bacterial Lpps 
are illustrated in Figure 3.  
Of note, not only variation with regard to the lipidation with di- or triacylated 
forms of Lpp as a final bacterial molecular structure are found in Lpp, but also 
the fatty acids, originating from membrane phospholipids and shaping the 
structure of the lipid-moiety, vary in length among different kind of bacteria 
(Buddelmeijer 2015). Nevertheless, in S. aureus, a long-chain fatty acid is 
characteristically presented at the N-acyl position of the lipid-moiety in the 
triacylated form of the Lpp (Kurokawa et al. 2009; Nguyen et al. 2017). 
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Figure 3. The biosynthetic pathway of bacterial lipoproteins.  
Lipoproteins are synthesised as preprolipoprotein precursors, which comprise 
an N-terminal signal peptide sequence (depicted as light-green cylinder), and 
are translocated across the cytoplasmic membrane (CM) by either the general 
secretory (Sec) or twin arginine translocation (TAT) pathways. The first 
enzyme, preprolipoprotein diacylglyceryl transferase (lgt) enables the transfer 
of a diacylglyceryl moiety to the indispensable cysteine residue (depicted as a 
beige circle with the letter, C), which forms a prolipoprotein. This lipid 
modification is followed by the second enzyme, prolipoprotein signal peptidase 
(lsp) that cleaves the signal peptide and generates a mature diacylated 
lipoprotein. For some bacterial lipoproteins, a third enzyme is required in 
order to form a mature triacylated lipoprotein. This lipid acylation is catalysed 
by either 1) apolipoprotein N-acyltransferase (lnt) and that occurs in most 
Gram-negative bacteria, or 2) lipoprotein N-acylation transferase system 
(lnsAB) and that was recently demonstrated to occur in Gram-positive 
Staphylococcus aureus. By mutating the catalytic lgt enzyme (Δlgt mutant), the 
maturation of lipoproteins is inhibited and can thus no longer be lipidated. 
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The importance of bacterial Lpp can be studied in numerous ways. Firstly, by 
inhibiting the maturation of the Lpp by mutating the specific catalytic 
enzymes, lgt and lsp, referred to as Δlgt and Δlsp deletion mutants, 
respectively. The Δlgt mutant leaves the cysteine residue unmodified, hence 
preventing lipidation to occur (Nguyen and Gotz 2016). However, as the signal 
peptide of pre-Lpp directs the immature form of the Lpp to the cytoplasmic 
membrane, as previously mentioned, the pre-Lpp still forms an initial linkage 
to the membrane (Nguyen and Gotz 2016). This procedure also prevents the 
lsp enzyme to fulfil its role due to the lack of pro-Lpp recognition (Nguyen and 
Gotz 2016). Regarding the Δlsp mutant, the first lipid-modification of the Lpp 
is initiated, however, the signal peptide remains intact rather than cleaved 
(Nguyen and Gotz 2016). This ultimately leads to a disturbed balance within 
the Lpp biosynthetic machinery and may result in improper accumulation of 
immature Lpp. 
Secondly, the significance of bacterial Lpp can also be investigated by 
isolation and purification of specific Lpp from the bacteria of interest, or 
thirdly, by using synthetic lipopeptides that resemble the lipid-moiety structure 
of bacterial Lpp, such as Pam3CSK4 (triacylated lipid form) or Pam2CSK4 
(diacylated lipid form). 
S. aureus Δlgt mutant strains have been implemented in all studies within my 
thesis (Paper I-III), whereas purified S. aureus Lpp Lpl1 along with the 
synthetic lipopeptides Pam3CSK4 and Pam2CSK4 have been used in Paper I 
and Paper III.  
The outcomes of bacterial deletion mutants as well as purified Lpp are briefly 
reviewed below.  
Table 1 is a list with structures of the compounds used in this thesis. 
 
 
 
 
Lipoproteins in Staphylococcus aureus infections 
30 
Table 1. The list of compounds used in this thesis. 
 
Adapted with minor modifications from Frontiers in Cellular and Infection 
Microbiology (Nguyen et al. 2016). 
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4.2 Types and functions of S. aureus 
lipoproteins 
S. aureus typically expresses Lpp in approximately 2-3% of its total bacterial 
genome (Babu et al. 2006). S. aureus Lpps can be grouped into different 
functional categories, whereby most of their functions appear to be achieved 
between the border of the bacterial cell wall and the membrane (Schmaler et 
al. 2010; Hutchings et al. 2009). 
Lpps represent a major class of surface proteins in S. aureus (Nguyen and Gotz 
2016). The role of Lpp in staphylococci involves various surface associated 
functions, such as nutritional acquisition as well as respiration, protein 
secretion, and invasion (Shahmirzadi, Nguyen, and Gotz 2016; Graf et al. 
2018). Other functions comprise synthesis of the bacterial cell wall, 
transmission of cell signalling, transport of electrons, and surface stress 
signalling response mechanisms (Graf et al. 2018). Lpps also participate in 
antibiotic resistance (Sutcliffe and Russell 1995). Hence, all these diverse 
functions are in principal for the bacterial cell envelope and its survival. 
Lpp is characteristically divided into two functional entities, whereby the 
protein-moiety serves and maintains the bacteria with its metabolic nutrition 
and function, whereas the lipid-moiety has a key role in anchoring the protein 
into the bacterial membrane as well as playing an important role in 
pathogenicity (Nguyen et al. 2017; Shahmirzadi, Nguyen, and Gotz 2016). As 
the lipid-moiety of S. aureus Lpp is situated at the outer leaflet of the 
cytoplasmic membrane, its triacylated fatty acid structure is incorporated into 
the membrane, while the protein-portion is directed towards the cell wall and 
beyond (Nguyen and Gotz 2016; Shahmirzadi, Nguyen, and Gotz 2016).  
To date, up to 70 Lpps have been detected in S. aureus, and the number of Lpps 
vary within various S. aureus genomes (Nguyen and Gotz 2016). By utilizing 
a Lpp predicting tool called ParSeq (Schmollinger et al. 2004), it was 
previously revealed that 55 putative Lpps, with the expression of a consisting 
signal peptide of regular length, exist in the genome of S. aureus N315 (Stoll 
et al. 2005). Many of those Lpps that exhibited similarities to proteins with 
notorious function were elucidated as transporters for iron, zinc, sugar, amino 
acid, teichoic acid, and oligopeptide among others, while other Lpps were 
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associated to various functions of enzymes, such as phage terminases, protein-
disulfide isomerase, and pyruvate-formate-lyase-activating enzyme, along 
with an additional set of other enzymatic functionalities (Stoll et al. 2005). On 
the other hand, a recent study re-evaluated Lpp more specifically in S. aureus 
USA300 strain (Shahmirzadi, Nguyen, and Gotz 2016), a pathogenic strain 
well-known for its multiple antibiotic resistance that serves as the predominant 
source of community-associated infections (Diep et al. 2006). This study 
proposed that S. aureus USA300 strain devotes 2.6% of its total gene coding 
ability possessing around 67 Lpps, an identification that was based on the 
PRED-LIPO prediction program (Shahmirzadi, Nguyen, and Gotz 2016). 
Nearly half of the total proportion were involved in transport of ions and 
nutrients, amino acids, peptides, enzymes and chaperons; 22% were classified 
as tandem Lpps including a specific set referred to as lipoprotein-like (lpl) 
genes; while 28% were of unknown function (Shahmirzadi, Nguyen, and Gotz 
2016). Of note, eight (12%) of the 67 identified Lpps were annotated as iron 
transporters (Shahmirzadi, Nguyen, and Gotz 2016), a relatively high 
proportion of Lpps specially designed to provide the bacteria with uptake of 
the needed iron. This is of essential importance during infectious conditions as 
iron is known to serve as a key element for the survival of the bacterium (Braun 
2001). As iron and nutrient transport alone accounts for 36% of the total 
function of S. aureus Lpp in this model strain (Shahmirzadi, Nguyen, and Gotz 
2016), one of the major roles of Lpps is to maintain and improve the metabolic 
activity and fitness of the bacterium. 
Another study inspecting the genome of a large set of complete genomic 
sequences of S. aureus strains, more precisely 123 genome sequences, recently 
revealed that an average number of 70 Lpps was estimated per strain, which 
equals to 2.6% of the bacterial genome (Graf et al. 2018). In addition, 
approximately 30% of all these S. aureus Lpps were annotated as importers of 
substrate-binding proteins through the ATP-binding cassette (ABC) transport 
system (Graf et al. 2018). Overall, this is in very close resemblance with the 
predicted Lpp number reported for the S. aureus USA300 strain (Shahmirzadi, 
Nguyen, and Gotz 2016). Since a large set of S. aureus Lpps has still not been 
characterized, the need to elucidate their function is fully warranted. 
Many pathogenic S. aureus strains harbour a genomic island, termed νSaα, 
which is designated as non-phage and non-staphylococcal cassette 
chromosome (Baba et al. 2008; Diep et al. 2006; Kuroda et al. 2001). 
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Furthermore, the νSaα-island is incorporated at certain chromosomal loci that 
are unique for the S. aureus genome (Tsuru and Kobayashi 2008). This 
genomic island possesses highly conserved genes, which comprise two clusters 
of tandem repeat sequences; one encodes exotoxin genes, whereas the other 
cluster encodes a number of homologous Lpps, termed lipoprotein-like (lpl) 
genes (Nguyen et al. 2015; Baba et al. 2008), all of which contain the 
conserved lipobox motif (Babu et al. 2006). The largest lpl gene cluster is 
preserved at the νSaα islet but additional clusters also occur at other 
chromosomal locations within the S. aureus genome, approaching to up to five 
lpl gene clusters per genome (Graf et al. 2018). The lpl genes are typically 
aligned in tandem paralogous clusters and share significant homologous 
properties when they originate from the same lpl cluster (Tsuru and Kobayashi 
2008). In the USA300 strain, nine lpl gene homologs are encoded in the 
genomic island (Nguyen et al. 2015; Shahmirzadi, Nguyen, and Gotz 2016). 
The first lpl gene product from the νSaα-specific lpl cluster, named Lpl1, has 
been extensively utilised in this thesis (Paper I and Paper III). Specifically, 
I have studied the effect of purified S. aureus Lpp, with or without the signal 
peptide, i.e. Lpp expressing the lipid-moiety, denoted Lpl1(+sp), or Lpp 
lacking the lipid-moiety, denoted Lpl1(-sp) in an animal model of skin and 
joint inflammation. 
As highlighted above, there are various types of Lpps in S. aureus with diverse 
functions. However, there is also a high variation with regard to their sizes as 
they range between 6-89 kDa in the S. aureus USA300 strain, with an average 
size designated between 30-50 kDa (Shahmirzadi, Nguyen, and Gotz 2016). 
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5. Lipoproteins and host immune 
response  
5.1 S. aureus Lpp – a potent immune stimulator 
It was widely believed that LTA and PGN, important cell wall components of 
S. aureus, are the main immune stimulators (Fournier and Philpott 2005; 
Takeuchi et al. 1999; Nguyen and Gotz 2016). However, recent studies suggest 
that the inflammation caused by LTA or PGN is more likely due to 
contamination with Lpp (Hashimoto, Tawaratsumida, Kariya, Kiyohara, et al. 
2006; Hashimoto, Tawaratsumida, Kariya, Aoyama, et al. 2006; Zahringer et 
al. 2008). This was proven in an experiment showing that a S. aureus Δlgt 
mutant strain displayed diminished innate immune activation in contrast to its 
parental Lpp-expressing strain (Stoll et al. 2005). Furthermore, using LTA 
from a S. aureus Δlgt strain, thus excluding any risks of Lpp contamination, 
dramatically decreased the innate immune response when compared to its 
parental strain, even though the structures of the LTA components were 
identical in both strains (Hashimoto, Tawaratsumida, Kariya, Kiyohara, et al. 
2006). Suspicions arose whether previous conclusions regarding LTA and 
PGN interaction with certain PRRs were due to Lpp contamination. In fact, 
several reports have indicated that S. aureus PGN, purified from the S. aureus 
Δlgt strain, lacked the ability to activate TLR2 (Volz et al. 2010; Schaffler et 
al. 2014). PGN was shown to co-localise with both nucleotide-binding 
oligomerization domain-containing protein 2 (NOD2) and TLR2 after 
internalization in mouse keratinocytes (Muller-Anstett et al. 2010). Overall, 
the theory that the innate immune sensation of S. aureus PGN or LTA operated 
exclusively through TLR2 was thus more likely a result of Lpp contamination, 
which further indicates the importance of S. aureus Lpp in immune activation 
via TLR2. 
In this thesis, we have utilised and explored the importance of S. aureus Lpp 
in our well-established murine S. aureus-induced septic arthritis models via 
two putative routes of infections, one of which is a local route of infection 
(Paper I), and a second one is a systemic route of infection (Paper II). In 
addition, the role of S. aureus Lpp in a murine skin inflammation and infection 
model was also investigated (Paper III). 
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5.2 S. aureus Lpp – a predominant TLR2 agonist 
Lpp maturation plays an essential role in immune signalling, inflammation, 
and pathogenicity during S. aureus infections (Stoll et al. 2005; Nguyen and 
Gotz 2016; Nguyen et al. 2015). The lipid structures of Lpp in S. aureus are 
known as MAMPs (Nguyen and Gotz 2016), being vital activators of the innate 
immunity as they play a potent role in alerting PRRs in host cells (Nguyen et 
al. 2017). Despite the fact that the lipid-moiety is embedded in the membrane, 
fractions from a minor proportion of mature Lpp in S. aureus tend to be 
released from its origin, enter the cell wall, and parts of the lipidated structures 
can be exposed on the cell surface (Stoll et al. 2005). The lipid modification is 
an absolute necessity in activating the host immune signalling as Lpp, that 
lacks the lipid structure, displays no such stimulatory activity (Stoll et al. 2005; 
Nguyen and Gotz 2016). Thus, the lipid-moiety functions as an important 
danger signal towards the host (Nguyen and Gotz 2016; Nguyen et al. 2017). 
Lpp and/or lipopeptides are recognised as the predominant ligands for TLR2 
(Hashimoto, Tawaratsumida, Kariya, Aoyama, et al. 2006; Aliprantis et al. 
1999; Brightbill et al. 1999). In fact, the unique thioether linkage that 
comprises a diacylglycerol moiety, which is commonly represented in all 
bacterial Lpps, serves as the core pattern for ligand recognition by TLR2 
(Nakayama, Kurokawa, and Lee 2012). TLR2 facilitates a broader range of 
ligand sensing due to heterodimerization with various co-receptors (Fournier 
2012; Lee, Avalos, and Ploegh 2012). In fact, this is the case during 
Lpp/lipopeptide recognition as TLR2 forms heterodimers with the additional 
receptors, TLR1 or TLR6 (Fournier 2012). Depending on the lipid structure of 
the Lpp, or the structure of synthetic lipopeptides, activation of the following 
TLR2 heterodimers occur: TLR2/TLR1 heterodimers sense triacylated Lpps 
and Pam3CSK4 lipopeptide (Jin et al. 2007), while TLR2/TLR6 heterodimers 
sense diacylated Lpps and Pam2CSK4 lipopeptide (Takeda, Takeuchi, and 
Akira 2002; Takeuchi et al. 2002; Kang et al. 2009). Thus, formation of such 
dimeric complexes through TLR2 with other TLRs is an important feature for 
the host immune cells in the recognition of distinct Lpp/lipopeptide structures 
(Takeda, Takeuchi, and Akira 2002). 
As TLR2 possesses this heterodimerisation ability, formation of the 
TLR2/TLR1 or TLR2/TLR6 dimerization complexes ultimately generates 
distinctive binding pockets, which enable incorporation and detection of the 
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different lipid structures found in bacterial Lpps and lipopeptides (Schenk, 
Belisle, and Modlin 2009). Upon interaction of TLR2 with Lpps/lipopeptides 
and the initiation of TLR2 dimerization, the two ester-bound fatty acid chains, 
i.e. the diacylglycerol moiety found in the thioether linkage of the cysteine 
residue in Lpps, bind to a pocket in TLR2 regardless of whether 
Lpps/lipopeptides possess a two- or three lipid chain (Jin et al. 2007; Schenk, 
Belisle, and Modlin 2009). In terms of the three-lipid chain (triacylated Lpp or 
Pam3CSK4), the amide-linked fatty acid binds to a hydrophobic pocket in 
TLR1 (Jin et al. 2007; Schenk, Belisle, and Modlin 2009). However, in the 
case of the two-lipid chain that comprises of a free α-amino-terminal 
(diacylated Lpp or Pam2CSK4), no such accommodation occurs, and 
heterodimerisation with TLR6 is facilitated instead (Kang et al. 2009). As the 
TLR1 pocket utilises the space to bind the N-acyl chain (Jin et al. 2007), the 
pocket in TLR6, on the other hand, is considerably smaller, has lower affinity 
towards the three-lipid chain, and is further blocked due to the phenylalanines 
being present (Kang et al. 2009). Overall, this shows that TLR2 interacts with 
bacterial Lpps/lipopeptides differently depending on their lipid chain structure, 
although the activation of both of these TLR complexes mediates the same 
signalling pathway (Schenk, Belisle, and Modlin 2009). The N-terminal 
cysteine modification in bacterial Lpp (diacylated or triacylated structures) 
ultimately commands which type of TLR2 complexes (TLR1 or TLR6) that 
will form and lead to Lpp-TLR2 interaction. The recognition of these S. aureus 
components elicits innate immune signalling that further modulates the host’s 
immune response and the inflammatory reactions (Nguyen and Gotz 2016). 
Upon Lpp-TLR2 interaction, an intracellular response is initiated, and in turn 
yields a cascade of events that comprise numerous phosphorylation steps 
ultimately culminating in NF-κB (nuclear factor kappa B) activation (Takeda 
and Akira 2004; Norgard et al. 1996; Rawadi et al. 1999). This signalling 
transduction pathway is mediated through the TIR domain-containing adaptor 
protein, MyD88 (myeloid differentiation primary response gene 88) (Takeda 
and Akira 2004). As MyD88 interacts with the cytoplasmic TIR domain of the 
TLR (Takeda and Akira 2004), a downstream signalling pathway is facilitated, 
which involves the recruitment of the kinases, IL-1 receptor-associated kinase 
(IRAK)-4 and IRAK-1 (Takeda and Akira 2004; Lin, Lo, and Wu 2010) that 
form a complex, termed the Myddosome (Lin, Lo, and Wu 2010). In turn, this 
signalling-mediated complex participates in the activation and interaction with 
the protein TRAF6 (tumour necrosis factor receptor–associated factor 6) 
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(Takeda and Akira 2004; Barton and Medzhitov 2003). The Myddosome 
complex mediates further phosphorylation that is associated with TRAF6 and 
leads to the activation of TAK1 (transforming growth factor β-activated kinase 
1) and the inhibitor of NF‐κB kinase (IKK) complex (Sato et al. 2005). 
Subsequently, this activates the NF-κB and permits the release of various 
cytokines and chemokines (Muzio et al. 1998; Sato et al. 2005). The pathway 
is illustrated in Figure 4.  
 
Figure 4. An overview of the TLR signalling pathway triggered by 
lipoproteins. 
Binding of diacylated or triacylated lipoprotein on TLR2/6 and TLR2/1, 
respectively, triggers a cascade of events that culminate in the release of pro-
inflammatory cytokines and chemokines. MyD88 = myeloid differentiation 
primary response gene 88, IRAK = interleukin-1 receptor-associated kinase, 
TRAF6 = tumour necrosis factor receptor–associated factor 6, TAK1 = 
transforming growth factor β-activated kinase 1, IKK = inhibitor of NF‐κB, 
NF-κB = nuclear factor kappa B. 
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Importantly, the construction of S. aureus Δlgt mutants along with improved 
methods for extraction and purification of Lpps (Stoll et al. 2005), have 
evidently proved that TLR2 is a major receptor exclusively activated by 
Lpps/lipopeptides (Bubeck Wardenburg, Williams, and Missiakas 2006; 
Hashimoto, Tawaratsumida, Kariya, Aoyama, et al. 2006; Hashimoto, 
Tawaratsumida, Kariya, Kiyohara, et al. 2006). Of note, purified manganese 
transport protein C (MntC) or staphylococcal iron transport protein C (SitC) 
serve as the first native S. aureus Lpp molecules to potently stimulate and to 
co-localise with TLR2 (Kurokawa et al. 2009; Muller et al. 2010).  However, 
the mechanism behind the Lpp release in S. aureus, and how the immune 
system actually facilitates the detection of Lpp remained elusive until very 
recently. It was suggested that the coordinated action of PSM peptides plays a 
role here (Hanzelmann et al. 2016; Schlatterer et al. 2018). Hanzelmann et al. 
demonstrated that these peptides enable S. aureus to release Lpp from their 
otherwise trapped cytoplasmic membrane lipid-linkage, and subsequently 
promote Lpp mobilization, a feature that may only occur in the presence of 
PSMs (Hanzelmann et al. 2016). Schlatterer et al. revealed that PSMs prompt 
the release of Lpp as vesicle components in S. aureus (Schlatterer et al. 2018). 
PSMs are therefore a necessity to present S. aureus Lpp to TLR2 and provoke 
its activation (Hanzelmann et al. 2016; Schlatterer et al. 2018). Intriguingly, 
acquisition of the lnsAB complex, which yields the triacylated form of Lpp in 
S. aureus, subsequently facilitates the transition of TLR2/TLR6 heterodimer 
to form a TLR2/TLR1 heterodimer instead (Gardiner et al. 2020). This 
suggests that the Lpp catalysing acyl transferase machinery along with lnsAB 
dictates which partner TLR2 will form heterodimer-complexes with. 
The addition of a third fatty acid at the amino group of the cysteine residue, 
which gives rise to a triacylated lipid structure, has a critical function for 
substrate recognition and the release of Lpps with efficient transport towards 
the outer membrane of Gram-negative bacteria through the Lol system 
(Fukuda et al. 2002). However, since Gram-positive bacteria lack an outer 
membrane (Silhavy, Kahne, and Walker 2010), the transporting system 
conducted by the Lol apparatus is not utilised. This indicates that the amide-
linked fatty acid at the N terminus in Gram-positive bacteria (Hutchings et al. 
2009) fulfils other functions beyond the involvement of Lol-mediated 
transport. 
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As the lit enzyme forms the lyso Lpp structure, possessing two acyl chains at 
the lipid-moiety (Armbruster and Meredith 2017), a resulting lyso structure 
was shown to preferentially mediate signalling via the TLR2/TLR6 complex 
despite the conduction of N-acylation (Armbruster, Komazin, and Meredith 
2019). This lyso Lpp structure was reported to exhibit attenuated TLR2 
recognition in contrast to the conventional di- or triacyled Lpp structures 
(Armbruster, Komazin, and Meredith 2019), which suggests that various 
modifications or remodelling of the N-terminal end leads to altered TLR2 
recognition. As a consequence, this might help the bacteria to evade immune 
recognition (Armbruster, Komazin, and Meredith 2019). Moreover, this 
further proves the concept that different lipid-moiety structures, including the 
lyso form, influence the TLR2-stimulating effect, since various Lpp 
modifications seem to function as either more or less dominant TLR2 agonists 
(Armbruster, Komazin, and Meredith 2019; Gardiner et al. 2020). The TLR2 
sensing ability varies considerably between different bacterial species (Nguyen 
and Gotz 2016). Nevertheless, among the immense range of virulence factors 
staphylococci dispose, Lpps are still considered as the main 
immunobiologically active components (Hashimoto, Tawaratsumida, Kariya, 
Aoyama, et al. 2006; Hashimoto, Tawaratsumida, Kariya, Kiyohara, et al. 
2006; Nguyen and Gotz 2016). 
It may seem paradoxical in bacterial evolution that Lpp evokes a cell-mediated 
immune response, specifically through TLR2-MyD88 signalling, thus 
initiating a battle between the S. aureus Lpp and the host immune system. 
However, this skilful bacterium is known to utilise various functions in order 
to escape immune recognition (Foster et al. 2014). A good example is 
staphylococcal superantigen-like protein 3 (SSL3), which is a TLR2 antagonist 
(Koymans et al. 2015). SSL3 prevents TLR2 dimerization with its co-receptors 
by forming a complex that partially closes off the pocket in the TLR2, which 
consequently inhibits the binding between Lpp and TLR2 (Koymans et al. 
2015). 
5.3 Importance of Lpps in iron acquisition and 
metabolic fitness 
As Lpps dispose a vast range of important functionalities in bacteria, lipidation 
of bacterial Lpps has been strongly associated with virulence (Nguyen and 
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Gotz 2016). In fact, Lpp maturation serves as a necessity in many bacterial 
species in their battle against the host (Kovacs-Simon, Titball, and Michell 
2011). Investigation of pathogenic properties induced by Lpp has mostly been 
conducted through implementation of lgt or lsp mutants in various in vitro and 
in vivo settings. Important parameters, such as the ability to acquire ions and 
nutrients as well as bacterial survival and bacterial proliferation have thus been 
studied in a broader extent. Lpp maturation has been shown to be of 
fundamental importance in iron acquisition, stimulating S. aureus bacterial 
growth, as S. aureus SA113 Δlgt mutant strain exhibited growth defects 
compared to its parental strain under nutrient-restricted conditions (Stoll et al. 
2005). In line with these results, we demonstrated that the Δlgt mutant had 
impaired growth compared with its parental strain in nutrient-poor conditions, 
while the Δlgt mutant and parental strain had similar growth rates in nutrient-
rich conditions (Paper II) (Mohammad et al. 2020). To our surprise, we also 
found in a co-cultivation assay that S. aureus Newman parental strain 
competed out the Δlgt mutant strain even in nutrient-rich conditions, although 
only during the early time-points (Paper II) (Mohammad et al. 2020), 
suggesting that Lpp expression promotes a competitive behaviour, which may 
be advantageous for the bacteria. Another study further underlined the 
importance of maturation of Lpp as a prerequisite for the bacteria in order to 
grow as well as to acquire iron both in vitro and ex vivo (Schmaler et al. 2009). 
Schmaler et al. demonstrated that while first starving the bacteria in an iron-
depleted environment, followed by supplementation with iron-sources, hence 
restoring the iron availability, SA113 Δlgt mutant strain exhibited impaired 
iron dependent bacterial growth compared to its parental strain (Schmaler et 
al. 2009). The concept of ‘better iron acquisition, better bacterial growth’ was 
further verified in an assay using streptonigrin, which is an iron-dependent 
antibiotic that craves iron in order to fulfil its bactericidal effect (Yeowell and 
White 1982). Δlgt displayed both less streptonigrin sensitivity and reduced 
accumulation of iron (Schmaler et al. 2009). Likewise, it was demonstrated 
that Lpp expression influenced the acquisition of iron during systemic 
infection as ex vivo assessment of mouse kidneys exposed to the SA113 
parental strain were more sensitive to streptonigrin than those exposed to 
SA113 Δlgt mutant strain (Schmaler et al. 2009). Altogether, these findings 
strongly imply the importance of Lpp maturation in iron uptake in S. aureus. 
In addition, Bubeck Wardenburg et al. demonstrated that the growth of 
Newman Δlgt mutant strain was retarded in contrast to its parental strain in 
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human whole blood and activated macrophages, although the proliferation rate 
was similar between the two strains in human sera (Bubeck Wardenburg, 
Williams, and Missiakas 2006). 
The expression of genes associated with Lpp and iron acquisition is known to 
be changed during iron deprivation (Allard et al. 2006), and expression of 
various staphylococcal Lpps that participate in the iron uptake has been shown 
to be greatly upregulated in such conditions (Morrissey et al. 2000; Heinrichs 
et al. 1999; Sebulsky and Heinrichs 2001; Dale, Sebulsky, and Heinrichs 2004; 
Hempel et al. 2011). Acquisition of iron is a pervasive feature employed by 
pathogens, such as S. aureus, in order to improve their survival and 
proliferation (Hammer and Skaar 2011; Haley and Skaar 2012). These 
evolving mechanisms in staphylococci have widely been attributed to be a part 
of their success during host-pathogen interactions (Sheldon and Heinrichs 
2012). 
Overall, Lpp in S. aureus plays an essential role in enabling the bacteria to 
acquire sufficient loads of iron under infectious conditions. As free iron ions 
are limited in the host environment and the iron supply is of critical importance 
for the survival of the staphylococcal pathogen (Sheldon and Heinrichs 2012; 
Hammer and Skaar 2011), inhibition of the Lpp function, through incomplete 
Lpp maturation, can be deleterious to the metabolic fitness of the bacterium, 
consequently prompting it to cease in the battle against the host. 
The largest iron reservoir in the host is represented by the heme iron, which 
serves as the preferred iron source for S. aureus (Skaar et al. 2004). As S. 
aureus seeks ways to acquire sufficient iron uptake during an infection, the 
host innate immune system employs defensive mechanisms by limiting the 
iron availability for the invading bacteria, functioning as one of the primary 
host defence responses during infection (Cassat and Skaar 2013; Haley and 
Skaar 2012). S. aureus can therefore utilise Lpp as an efficient iron transporter 
in order to circumvent this nutritional immunity, increase its chances of 
survival and consequently cause a disease. Therefore, maturation of Lpp plays 
a potent role during infection as it possesses the ability to boost the bacteria 
with the needed iron- and nutrient supply. The loss or disturbances of iron-
regulated systems during S. aureus infections are strongly associated with 
attenuated virulence (Torres et al. 2006; Pishchany et al. 2014), which further 
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implies the critical role iron serves in the pathogenesis of diseases this 
bacterium causes. 
In other Gram-positive bacteria, such as Streptococcus pyogenes, three specific 
Lpps designated HtsA, FtsB and MtsA are important in iron transportation, and 
the transcription levels of those genes were increased in iron-limited 
environments (Lei et al. 2003; Hanks et al. 2005; Smoot et al. 2001; Janulczyk, 
Pallon, and Bjorck 1999). In another bacteria, Streptococcus pneumoniae, a 
trio of Lpps denoted pneumococcal iron acquisition, pneumococcal iron 
uptake, and pneumococcal iron transporter, function as substrate-binding 
proteins. These are critically involved in iron acquisition, and bacteria 
displayed attenuated growth or diminished virulence in murine infection 
models when utilising mutant strains of these specific Lpps in comparison to 
their parental strains (Brown, Gilliland, and Holden 2001; Brown et al. 2002). 
A pneumococcal mutant strain defective in all three Lpps exhibited growth 
defects in vitro in a variety of iron-restricted conditions, severely decreased the 
55FeCl3 accumulation, and reduced the sensitivity towards streptonigrin 
(Brown et al. 2002). In addition, a Streptococcus pneumoniae Δlgt mutant 
exhibited reduced bacterial proliferation in vitro in cation-depleted conditions, 
impaired the acquisition of several cations, including iron, and resulted in 
growth defects in human blood and bronchoalveolar lavage fluid obtained from 
mice (Chimalapati et al. 2012). Furthermore, in Streptococcus agalactiae, the 
in vitro bacterial growth was impaired in Lpp mutants of Δlgt, Δlsp or 
Δlgt/Δlsp compared to their parental strain in nutrient-poor medium, indicating 
the importance of Lpp in metabolic fitness of this bacterium under restrictive 
conditions (Henneke et al. 2008). 
Deletions of lgt and lsp genes are known to promote the release of unprocessed 
and defective Lpps in S. aureus (Stoll et al. 2005; Nguyen and Gotz 2016). It 
was previously revealed that substantial loss of Lpp was detected from the 
cytoplasmic membrane upon deletion of the lsp gene in Gram-positive 
Streptomyces coelicolor (Thompson et al. 2010). This Δlsp mutant was also 
associated with inhibited bacterial growth as well as with formation of 
uncharacteristic small-sized colonies in contrast to its parental strain 
(Thompson et al. 2010).  
In contrast to iron-restricted conditions, deletion of lgt tends to have minor 
effects on the bacterial growth in enriched- or complete media in various 
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Gram-positive bacteria, strongly suggesting that bacterial viability is mostly 
hampered only under stressful conditions and nutrient limitation. This has been 
reported for example in S. aureus (Paper II) (Mohammad et al. 2020; Stoll et 
al. 2005), as well as in other Gram-positive bacteria, such as Streptococcus 
pneumoniae (Petit et al. 2001; Chimalapati et al. 2012), Streptococcus 
agalactiae (Henneke et al. 2008; Bray, Sutcliffe, and Harrington 2009), 
Streptococcus sanguinis (Das et al. 2009), Streptococcus suis (Wichgers 
Schreur et al. 2011), Streptococcus mutans (Arimoto and Igarashi 2008), 
Streptococcus equi (Hamilton et al. 2006), Bacillus subtilis (Leskela et al. 
1999), and Listeria monocytogenes (Baumgartner et al. 2007). In 
Streptococcus gordonii, a Δlgt mutant exhibited a similar growth pattern as its 
parental strain, and did neither alter the size nor the cell morphology, while 
assessed by electron microscopy (Kim et al. 2018). 
Earlier reports have indicated that the lsp gene is of less importance in 
numerous Gram-positive bacteria with regard to ability to grow in vitro as lsp-
deficient mutants displayed similar growth rates to those of their parental 
strains (de Greeff et al. 2003; Sander et al. 2004; Venema et al. 2003; Reglier-
Poupet et al. 2003; Tjalsma et al. 1999). Yet, in Gram-negative bacteria, such 
as Salmonella typhimurium and Escherichia coli, lgt- or lsp-deficient mutants 
result in fatal outcomes for the bacteria (Gan et al. 1993; Yamagata et al. 1983), 
underlining the critical role of Lpp maturation in the survival of Gram-negative 
bacteria (Hutchings et al. 2009). 
5.4 S. aureus Lpp – in vitro effects 
The use of S. aureus Δlgt mutants as well as purified Lpp compounds and 
synthetic lipopeptides have demonstrated Lpps important role in triggering the 
release of cytokines and chemokines as a response of host immune defence 
mechanisms. 
Synthetic lipopeptides are well-known to be potent stimulators of human 
monocytes and macrophages with subsequent secretion of various cytokines 
(Kreutz et al. 1997; Hoffmann et al. 1988).  S. aureus Δlgt mutants are 
associated with impaired production of pro-inflammatory cytokines and 
chemokines, including IL-6, IL-8, and MCP-1, in various human cells, such as 
the human monocytic cell line (MonoMac6), the human pulmonary epithelial 
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cell line (A549), and in human umbilical vein endothelial cells, in contrast to 
its parental strain (Stoll et al. 2005). Furthermore, both TNFα and IL-10 levels 
were diminished over time in MonoMac6 cells (Stoll et al. 2005). In another 
human monocytic cell line, referred to as THP-1 cells, cell stimulation with 
heat-killed S. aureus Δlgt mutant was associated with lower production of 
TNF, IL-1β and IL-8, in contrast to those cells that were stimulated with the 
heat-killed S. aureus parental strain (Kang et al. 2011). Also, S. aureus Δlgt 
mutants were associated with impaired TLR2-MyD88-mediated cytokine 
production (IL-1, IL-6, IL-10 and TNF) in mouse peritoneal macrophages, 
whereas the S. aureus parental strain induced early and strong cytokine release 
(Schmaler et al. 2009). Purified S. aureus SitC is well-known to induce TNF 
and IL-6 expression in murine peritoneal macrophages in a TLR2-MyD88 
dependent manner (Kurokawa et al. 2009). The release of such pro-
inflammatory cytokines was also demonstrated in human monocytes and 
mouse keratinocytes, and in TLR2 expressing HEK cells (Muller et al. 2010). 
Our results show that purified S. aureus Lpp, Lpl1, upon stimulation of 
peritoneal macrophages induced a quick and dose-dependent release of the 
neutrophil-chemoattractant, MIP-2 and KC as well as monocyte-
chemoattractant MCP-1 (Paper I) (Mohammad et al. 2019). These strong and 
rapid effects were observed already four hours after stimulation, and were 
dependent on the lipid- and not the protein-moiety. In fact, purified Lpl1(+sp), 
expressing Lpp, induced similar levels as the positive control, while Lpl1(-sp), 
lacking the lipid-moiety, was only capable to exhibit similar stimulation levels 
as the negative control for the assessed chemokine (Paper I) (Mohammad et 
al. 2019). These findings were only observed in the peritoneal macrophage 
supernatants collected from the C57BL/6 wild-type and not in the TLR2 
deficient mice, and were thus mediated through the PRR, TLR2 (Paper I) 
(Mohammad et al. 2019). The importance of S. aureus Lpp and its lipidation 
was further verified by the fact that the triacylated lipid-moiety presented in 
Pam3CSK4 synthetic lipopeptide induced similar MIP-2, KC and MCP-1 
levels as the purified Lpl1(+sp) compound (Paper I) (Mohammad et al. 2019). 
In addition to the neutrophil- and monocyte chemoattractant chemokines, the 
pro-inflammatory cytokine, TNFα, was also induced in a TLR2-dependent 
manner upon Lpl1(+sp) and Pam3CSK4 stimulation in both mouse peritoneal 
macrophages and in splenocyte cultures (Paper I) (Mohammad et al. 2019). 
Overall, our findings indicate that S. aureus Lpps are potent immune 
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stimulators that induce rapid release of important chemokines and cytokines 
from immune cells exclusively via TLR2. 
On the other hand, our data revealed that SA113 parental strain and Δlgt mutant 
strain proliferated similarly in mouse whole blood during a two hour 
incubation (Paper I) (Mohammad et al. 2019), which are not in corroboration 
to previous findings in human whole blood (Bubeck Wardenburg, Williams, 
and Missiakas 2006). However, parameters such as the assessed time points, 
different S. aureus strains (SA113 vs. Newman), and the different sources of 
whole blood (mouse vs. human) might explain these discrepancies. 
Nevertheless, in the model of systemic infection, S. aureus Lpp was 
attributable in inducing a more systemic inflammatory status, whereby the 
Newman parental strain was associated with higher levels of IL-6 and KC, but 
not MCP-1 (Paper II) (Mohammad et al. 2020). No differences between the 
parental strain and the lgt deficient mutant strain were observed in TLR2 
knockout mice, suggesting that the cytokine response was dependent on TLR2 
(Paper II) (Mohammad et al. 2020). Although S. aureus Newman parental 
strain had higher bacterial proliferation in the presence of activated murine 
macrophages compared with Newman Δlgt mutant strain, the phagocytic 
capacity of macrophages was not affected by the Lpp expression (Bubeck 
Wardenburg, Williams, and Missiakas 2006). These results are in 
corroboration with our data whereby purified S. aureus Lpl1 did not influence 
the phagocytic capacity of macrophages (Paper I) (Mohammad et al. 2019). 
Gardiner et al. studied the importance of lnsAB on the response of immune 
stimulation and demonstrated using HEK-TLR2 cells that the expression of IL-
8 increased approximately 10 times upon deletion of either of the two genes, 
lnsA or lnsB (Gardiner et al. 2020). This suggests that an intact lnsAB system 
is advantageous for S. aureus in evading TLR2 immune recognition. 
Furthermore, various staphylococcal species possess varying lengths of the N-
acylation at the N termini of the cysteine residue within the Lpp lipid-moiety: 
the commensal pathogens S. aureus and S. epidermidis carry a long-chain N-
acylated fatty acid, while the non-commensal, non-pathogenic S. carnosus 
(Rosenstein and Gotz 2013; Biswas et al. 2009) carries a short-chain N-
acylated fatty acid, which corresponds to a heptadecanoyl fatty acid and a 
acetyl fatty acid, respectively (Nguyen et al. 2017). Nguyen et al. revealed that 
S. carnosus was capable to induce ten-fold higher TLR2-mediated cytokine 
responses compared to the observed levels that were induced by S. aureus and 
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S. epidermidis (Nguyen et al. 2017). Furthermore, both TNFα and IL-8 
secretion were strongly upregulated by S. carnosus in MonoMac6 and HEK-
TLR2 cells in comparison with several S. aureus strains, including SA113, 
HG003, and the MRSA strain, USA300 (Nguyen et al. 2017). This concept 
was further proved as purified SitC Lpp extracted from S. carnosus yielded 
higher induction of TLR2-mediated IL-8 chemokine in contrast to the SitC Lpp 
that was extracted from S. aureus (Nguyen et al. 2017). This was also 
confirmed in human monocyte-derived dendritic cells whereby the levels of 
various pro-inflammatory cytokines were elevated in a similar manner 
(Nguyen et al. 2017). Overall, these findings are in line with previous reports 
that showed that different modifications of the lipid-moiety display diverse 
TLR2 activations (Armbruster, Komazin, and Meredith 2019; Gardiner et al. 
2020). Interestingly, the expression of other S. aureus components, more 
precisely CP can mask S. aureus Lpps and attenuate the Lpp recognition and 
TLR2 activity (Hilmi et al. 2014). 
It was recently demonstrated in HeLa cells that lpl from the νSaα island alters 
the host cell cycle, delays its transition, which consequently leads to increased 
cell invasion (Nguyen et al. 2016). This effect was shown to be mediated by 
the secretion of cyclomodulin (Nguyen et al. 2016), which functions as 
bacterial toxin that is known to disturb the regular course of the host cell cycle 
(Taieb, Nougayrede, and Oswald 2011). Cyclomodulin seems to be utilised by 
S. aureus as a part of its invasive nature as well as to induce bacterial 
proliferation within the host cells (Alekseeva et al. 2013). Several elements 
that play a role in the involvement of lpl and its subsequent invasiveness were 
recently addressed by Nguyen and colleagues (Nguyen et al. 2018). In fact, it 
was revealed that not only the bacterial growth phases of S. aureus play an 
important role but also that the host side contributes to such effects since TLR2 
expressing cells promoted higher invasive frequencies (Nguyen et al. 2018). 
Nguyen et al showed that deletion of the entire lpl operon in S. aureus USA300 
strain resulted in attenuated induction of pro-inflammatory cytokines in human 
monocytes, macrophages and keratinocytes, in contrast to the parental strain 
expressing the lpl gene cluster (Nguyen et al. 2015). To verify the observed 
phenomenon, the lpl cluster was cloned into another S. aureus strain, HG003, 
which naturally lacks lpl genes, and this resulted in increased production of the 
pro-inflammatory cytokines (Nguyen et al. 2015). The purified lipidated Lpp, 
Lpl1, was further shown to evoke a TLR2-dependent response (Nguyen et al. 
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2015). A recent study revealed that the cluster of lpl proteins in S. aureus were 
upregulated in a MRSA strain during sub-inhibitory exposure to β-lactam 
antibiotics (Shang et al. 2019). This suggests that S. aureus Lpp, and more 
specifically lpl, has characteristics of virulent nature that S. aureus can utilise 
in order to enhance MRSA pathogenicity. 
5.5 Lpp – in vivo effects: the role in virulence 
and pathogenicity  
Besides its vital role in maintaining and upregulating the fitness of the bacteria 
(Shahmirzadi, Nguyen, and Gotz 2016), bacterial Lpp possesses a variety of 
key functions, some of which serve critical roles during infectious and 
inflammatory conditions. In most, but not all cases, maturation of Lpp has been 
strongly associated with enhanced pathogenic invasion, bacterial survival, and 
immune activation (Nguyen and Gotz 2016; Shahmirzadi, Nguyen, and Gotz 
2016). 
We reported that S. aureus Lpps play various roles in different murine models 
(Paper I-III). In a local knee arthritis model, S. aureus Lpps mediated severe 
arthritogenic effects in NMRI and C57BL/6 wild-type mice, but not in TLR2 
deficient mice after intra-articular knee joint challenge with the purified Lpp, 
Lpl1(+sp) (Paper I) (Mohammad et al. 2019). The arthritogenic properties 
were mediated through the lipid-moiety, since Lpl1(-sp), comprising only of 
the protein-moiety, lacked the ability to cause any knee joint swelling. In 
addition to the observed long-lasting macroscopic arthritic effect in the 
Lpl1(+sp) group, which was detected already within 24 hours post-injection, 
Lpl1 contributed to local knee synovitis in a dose-dependent fashion. The 
histological sections revealed that Lpl1 induced synovitis even when 
administered at the nanogram level, indicating that S. aureus Lpps are highly 
potent. Intriguingly, when challenging the mice with an Lpl1 dose at the 
microgram level, all joints developed bone erosions within 10 days post-
injection (Paper I) (Mohammad et al. 2019). 
Prior to this study, we reported that murine knee joints, challenged with 
antibiotic-killed S. aureus, displayed severe bone erosion and long-lasting 
arthritis (Ali, Zhu, et al. 2015). This aspect is indeed very clinically relevant 
since patients suffering of septic arthritis are likely to develop irreversible 
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permanent joint destruction, even after successful bacterial eradication through 
the standard treatment procedure (Goldenberg 1998). Since the S. aureus cell 
wall components were responsible for causing this inflammatory effect in the 
joints, partially via TLR2 (Ali, Zhu, et al. 2015), this prompted us to study the 
significance of S. aureus Lpps as we hypothesised that Lpps might be one of 
the inducers. Indeed, we were able to verify this hypothesis, and also elucidated 
the cellular mechanism by showing that monocytes/macrophages were the 
responsible cell type mediating the Lpl1-induced effect in the local knee joints 
through TLR2-dependent mechanisms (Paper I) (Mohammad et al. 2019). 
This further strengthens the concept that the disease severity of septic arthritis 
is at least partially mediated by an exaggerated immune response, which is 
triggered by specific bacterial components, such as Lpp (Paper I) (Mohammad 
et al. 2019), which is in corroboration with previous reports (Ali, Zhu, et al. 
2015; Deng et al. 1999). 
In a local knee septic arthritis model triggered by intra-articular injection of 
living bacteria, SA113 Δlgt mutant strain induced more knee swelling 
compared to its parental strain, which coincided with higher bacterial burden 
in the local knee and increased IL-6 expression (Paper I) (Mohammad et al. 
2019). In contrast, in a murine sepsis model, lower bacterial loads were found 
in knee joints of mice who received intravenous injection of the same strain 
(Schmaler et al. 2009), which once again suggests that Lpps behave differently 
in different murine models, depending on the route of infection, the organ of 
interest, and the assessed time points. In fact, in our haematogenous septic 
arthritis model, increased bacterial persistence was observed in both C57BL/6 
wild-type and TLR2 deficient murine kidneys when inoculated intravenously 
with the Newman parental strain (Paper II) (Mohammad et al. 2020). This is 
in agreement with earlier reports showing that different organs, including the 
kidneys, exhibited higher bacterial loads when infected with SA113 parental 
strain in comparison to the Δlgt mutant strain, independent of TLR2 and 
MyD88 signalling (Schmaler et al. 2009). In addition, USA300 MRSA parental 
strain led to higher bacterial burden in kidneys of Balb/c mice compared to its 
Δlpl mutant strain, lacking the lpl gene cluster (Nguyen et al. 2015). 
Lpp was also shown to enhance the invasiveness of S. aureus in skin infection 
by displaying higher bacterial counts when mice were epicutaneously infected 
with the USA300 parental strain (Nguyen et al. 2015). A similar phenomenon 
was observed when we subcutaneously infected the mice with the SA113 or 
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the Newman strain (Paper III). This shows that different S. aureus Lpp-
expressing strains give rise to similar virulent characteristics in two different 
skin infection models. In Gram-positive Bacillus anthracis, lgt-deficiency 
contributed to diminished virulence in mouse skin tissue (Okugawa et al. 
2012). In another Gram-positive bacteria, Streptococcus pyogenes, skin 
infection of mice with an lsp-deficient strain led to impaired virulence with 
less pronounced skin lesions in comparison to its parental strain (Weston, 
Brenot, and Caparon 2009). Purified S. aureus Lpps were shown to promote 
murine skin inflammation through activation of dendritic cells in an 
intradermal injection model (Saito and Quadery 2018). Likewise, induced skin 
inflammation was also observed in our subcutaneous skin injection model 
(Paper III).  
The cellular mechanism behind the lower bacterial load in the murine knee 
joints intra-articularly inoculated with Lpp-expressing S. aureus was 
elucidated using co-injection of live bacteria with purified S. aureus Lpp or 
synthetic lipopeptides. This resulted in bacterial eradication in the knee joints 
– a phenomenon that was mediated through TLR2-dependent mechanisms with 
neutrophils acting as the main phagocytic cell engulfing the bacteria (Paper I) 
(Mohammad et al. 2019). In fact, enhanced levels of the neutrophil attracting 
chemokines, KC and MIP-2, were observed in the supernatants of knee 
homogenates (Paper I) (Mohammad et al. 2019). Our data indicate that not 
only purified S. aureus Lpp but also Lpps immersed in live bacteria are able to 
activate a powerful innate immune response. The elevated levels of the same 
chemokines were also observed in the skin homogenates upon subcutaneous 
injection with purified S. aureus Lpp (Paper III), strongly suggesting that 
Lpps play a potent role in triggering local inflammatory responses in different 
organs. In a murine sepsis model, it was recently demonstrated that mice pre-
treated with the synthetic lipopeptide, Pam3CSK4, had decreased bacterial 
burden and increased survival following infection with a S. aureus MRSA 
strain (Huang et al. 2017). 
In the haematogenous septic arthritis model, expression of Lpp in S. aureus 
increases mortality, weight loss, and cytokine production and decreases 
bacterial clearance independent of TLR2, indicating the important role of Lpp 
expression in bacterial fitness and virulence (Paper II) (Mohammad et al. 
2020). TLR2, as a Lpp receptor, plays a role in the host defence against 
infection, as TLR2 deficient mice infected with the Newman parental strain 
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displayed enhanced arthritis symptoms as well as increased weight loss, 
mortality and bacterial burden in kidneys compared to the wild-type controls 
(Paper II) (Mohammad et al. 2020). This result was not so surprising since 
several reports previously showed that TLR2 deficient mice are significantly 
more susceptible to S. aureus-induced infections and display increased 
bacterial loads in different organs in comparison to their wild-type counterparts 
(Schmaler et al. 2009; Stenzel et al. 2008; Miller et al. 2006; Sun et al. 2006; 
Takeuchi, Hoshino, and Akira 2000).  
In the local knee arthritis model, we demonstrated that the destructive arthritis 
caused by Lpp is TLR2-dependent (Paper I) (Mohammad et al. 2019); 
possibly due to an excessive inflammatory reaction. However, in the 
haematogenous septic arthritis model, we showed that the destructive arthritis 
caused by Lpp-expressing S. aureus was TLR2-independent. Multi-functions 
of Lpp i.e. maintaining the metabolic nutrition and fitness, bacterial survival 
and pathogenicity during host-interactions, or its ability to evade immune 
recognition or to trigger various immune responses upon invasion are all of 
significant importance during infection with live S. aureus expressing Lpp.  
Our findings from the murine haematogenous septic arthritis model and from 
the local knee arthritis model are illustrated in Figure 5. 
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Figure 5. Schematic illustration of S. aureus lipoprotein (Lpp) effects in 
haematogenous and local S. aureus arthritis models.  
Left panel: S. aureus parental strain, expressing Lpp (S. aureus Lpp), 
significantly aggravated systemic infection with increased mortality, weight 
loss, and bacterial burden in the kidneys (1) compared to its lgt mutant strain, 
lacking Lpp (S. aureus Δlgt) (2). However, both S. aureus strains had similar 
outcomes with regard to bone erosion. Right panel: Lpp had dual effects in the 
local knee model. Intra-articular injection of purified Lpp (S. aureus Lpl1) 
induced rapid TLR2-dependent infiltration of phagocytes. Moreover, Lpl1 
caused severe joint inflammation and bone erosions dependent on 
monocytes/macrophages through TLR2 (3). On the other hand, live S. aureus 
Lpp acted as adjuvants, triggering recognition by TLR2 and subsequent 
neutrophil recruitment, leading to more efficient bacterial killing and 
diminished bone destruction (4). CFU = colony forming units. 
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Lpps have emerged as an important factor during the pathogenesis of S. aureus 
systemic infections (Paper II) (Schmaler et al. 2009; Mohammad et al. 2020). 
This was further strengthened in other Gram-positive bacteria. Petit et 
al. showed that Lpp from Streptococcus pneumoniae was imperative for the 
bacteria to initiate and maintain infection in an intranasal model (Petit et al. 
2001). In addition, deletion of the lgt gene in Streptococcus pneumoniae was 
associated with significantly attenuated virulence in different animal models 
such as pneumonia, sepsis, and significantly diminished nasopharyngeal 
colonization of the mice (Chimalapati et al. 2012). In another Gram-positive 
bacteria, Streptococcus gordonii, mice receiving the strain lacking Lpp had 
increased survival compared to the mice who received the parental strain 
expressing Lpp, further illustrating the pathogenic role of Lpp (Kim et al. 
2018). 
In Gram-positive Streptococcus equi, lack of Lpp markedly ameliorated 
disease severity in a mouse but not horse model of strangles, an upper tract 
infectious disease that is mostly prevalent in horses (Hamilton et al. 2006). 
Furthermore, in a sepsis model of Listeria monocytogenes, Lpps were found to 
be critical virulence determinants. Mice infected with the strain expressing Lpp 
succumbed to disease within few days while none of the mice in the group 
infected with a strain lacking Lpp died (Machata et al. 2008). In 
Mycobacterium tuberculosis, Lpp was also shown to be a virulent factor in a 
tuberculosis model. Using a mutant strain, lacking the lsp enzyme, 
significantly attenuated disease severity, and the observed results were 
independent of the genetic background of the mice (Sander et al. 2004). 
However, there are very few studies showing contrasting results. In Gram-
positive Streptococcus agalactiae, Lpp mediated protection via TLR2 with 
increased survival compared to its lgt-deficient strain in a murine sepsis model 
(Henneke et al. 2008). In addition, another study indicated that S. aureus Δlgt 
mutant was hypervirulent in contrast to its parental strain (Bubeck 
Wardenburg, Williams, and Missiakas 2006). Surprisingly, in the same article, 
the authors demonstrated that the lsp-deficient strain exhibited attenuated 
virulence (Bubeck Wardenburg, Williams, and Missiakas 2006), which is more 
in line with many other studies. One could speculate that these contradictory 
findings might be due to variations in animal species and age, bacterial dose or 
bacterial strain, duration of the course of infection, or that the generation of the 
lgt deletion mutant might have been processed differently in the reported 
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studies, which might convey these divergent outcomes on lipidation and 
maturation of staphylococcal Lpp in murine staphylococcal sepsis. 
Nevertheless, our conclusion from the majority of the previous studies is that 
bacterial Lpps are pathogenic in systemic and skin infections. Gram-positive 
bacterial Lpps and their differential roles in different in vivo models are 
summarised in Table 2. 
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Table 2. Gram-positive bacterial lipoproteins and their distinct role in 
different in vivo animal models. 
 
 
Lpp = lipoproteins, Δlgt = deletion mutant of preprolipoprotein diacylglyceryl 
transferase, Δlsp = deletion mutant of prolipoprotein signal peptidase. 
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6. Conclusion  
 
S. aureus Lpps play a differential role depending on the affected organ and 
route of injection, as described below. 
In Paper I, Lpps gave rise to a dual function in local S. aureus arthritis models. 
On the one hand, purified Lpp, but not TSST-1 or PGN, induced chronic 
macroscopic arthritis. Intra-articular injection with Lpps induced rapid TLR2-
dependent infiltration of monocytes/macrophages and neutrophils. 
Furthermore, S. aureus Lpps caused severe joint inflammation and bone 
erosions, which were mediated by monocytes/macrophages through TLR2. 
On the other hand, Lpp expression in S. aureus led to reduced bacterial burden 
in the arthritic knee joints. The observed phenomenon was due to Lpp acting 
as adjuvant and triggering recognition by TLR2 followed by subsequent 
neutrophil recruitment, leading to more efficient bacterial killing and 
diminished bone destruction.  
In Paper II, S. aureus Lpps were found to be prominent virulence factors 
independent of host TLR2 expression. Mice that were intravenously inoculated 
with the S. aureus Lpp-expressing parental strain succumbed more to the 
disease, had increased weight loss, and exhibited impaired bacterial clearance 
in their kidneys, in comparison to the S. aureus Δlgt mutant strain, lacking Lpp 
expression. Notably, the worst outcome was observed in mice lacking TLR2 
and inoculated with the S. aureus parental strain, strongly indicating the 
protective role of TLR2 in haematogenous spread of S. aureus-induced septic 
arthritis. However, in contrast to the local septic arthritis model, S. aureus Lpp 
exhibited a limited role on bone erosion. 
In Paper III, S. aureus Lpps were associated with severe inflammatory 
response in the skin model. The observed skin lesions and inflammation were 
mediated through TLR2-dependent mechanisms. Lpp contributed to the influx 
of innate immune cells in a similar manner as observed in Paper I with 
monocytes/macrophages as well as neutrophils recruited to the local tissue. In 
addition, subcutaneous injection of S. aureus parental strain was associated 
with elevated bacterial burden in the skin biopsies. Importantly, Lpp 
maturation contributed to staphylococcal immune evasion. The main findings 
of our results are summarised in Paper III.
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7. Future perspectives 
 
In Paper I, we investigated the role of S. aureus Lpp on the induction of bone 
erosion and clarified the cellular and molecular mechanism of how S. aureus 
Lpps induce joint inflammation and bone erosion in murine septic arthritis. Our 
next objective is to study Lpps impact on the bone mineral density in septic 
arthritis as the bone mineral density is known to be quickly reduced in mice 
with septic arthritis (Verdrengh et al. 2006). Bone mass measurements provide 
important information with regard to the patient’s bone health and thus serve 
as an important clinical tool for diagnosing osteoporosis and determining the 
risk of bone fractures (Richards et al. 2008). Due to S. aureus Lpps’ potent role 
in causing severe joint inflammation and focal bone damage in mice (Paper 
I), we plan to assess how this affects the bone loss over time as well as to 
elucidate whether different immune cell depletions influence the bone mineral 
density in Lpp-induced arthritis. 
Furthermore, as mentioned above, there are two main different structures of 
lipid-moieties from bacterial Lpps; diacylated and triacylated Lpps.  Our future 
aim is to go deeper and compare different lipid-moieties of the staphylococcal 
species, S. aureus and S. carnosus, as well as the synthetic lipopeptides, 
Pam3CSK4 and Pam2CSK4, and investigate their role in the induction of bone 
erosion.  To our knowledge, there are currently no studies available regarding 
the role of di- and tri-acylated Lpps on the induction of bone damage. We 
hypothesise that the diacylated Lpp structure is more potent inducer of bone 
erosion. As outlined before, the degree of acylation of the lipid-moiety impacts 
the immune response. Importantly, Nguyen et al. recently showed that lipid-
moieties of Lpps from different bacterial species significantly differ regarding 
their immune stimulatory activity (Nguyen et al. 2017). In addition, earlier 
studies conducted on skin resident cells demonstrated that di- but not 
triacylated Lpps suppressed the immune tolerance, a phenomenon that was 
mediated through IL-6 release, and the subsequent induction and accumulation 
of myeloid-derived suppressor cells (Skabytska et al. 2014). 
Finally, it has recently been proposed that combination of different 
staphylococcal MAMPs might exert an additive or possibly even a synergistic 
effect in immune stimulation (Nguyen and Gotz 2016). S. aureus Lpps as well 
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as PGN, are known MAMPs of S. aureus (Nguyen and Gotz 2016). It is known 
that most staphylococcal infections are successfully promoted by coordinated 
action of different virulence factors rather than a single virulence factor 
(Fournier and Philpott 2005). In fact, co-stimulation of dendritic cells with 
PGN and synthetic lipopeptide, enhanced immune stimulatory effects 
compared to PGN or lipopeptide stimulation alone (Schaffler et al. 2014). 
Therefore, we plan to determine whether Lpps and PGN act synergistically in 
staphylococcal skin infections. 
As we have seen through the above studies, Lpp gave rise to different outcomes 
in different organs. What does this depend on? We speculate that the different 
clinical outcomes might be explained by the anatomic differences, composition 
difference of immune cells and distribution of blood vessels in the different 
organs. However, more detailed studies are warranted in the future to answer 
this question. 
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